Spinal fusion implants and devices and methods for deploying such implants

- Spinal Elements, Inc.

Methods and apparatus are disclosed for distracting tissue. The devices and methods may include insertion of first and second elongated members into the space between two tissue layers, with an augmenting elongated member inserted therebetween to form a distraction device between the tissues to be distracted. The distraction device defines a generally annular configuration, with a locking member secured to one of the elongated members at a plurality of locations to maintain the distraction device in the generally annular configuration. The augmenting elongated member may be shorter than the first and second elongated members such that a window is defined between the proximal and distal ends of the augmenting elongated member when the distraction device and the first and second elongated members are in the generally annular configuration. Bone graft material or bone filler may be introduced into the interior of the distraction device through the window.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The present application is a reissue of U.S. Pat. No. 10,231,843 which issued Mar. 19, 2019, from U.S. patent application Ser. No. 15/276,147, filed Sep. 26, 2016, which is a continuation of U.S. patent application Ser. No. 13/803,322, filed Mar. 14, 2013, now U.S. Pat. No. 9,480,574, the contents of which are incorporated herein by reference.

BACKGROUND Field of the Disclosure

The present invention generally relates to apparatus and methods employed in minimally invasive surgical procedures and more particularly to various aspects of apparatus and methods for separating and/or supporting tissue layers, especially in the disc space of the spine.

Description of Related Art

A variety of physical conditions involve two tissue surfaces that, for diagnosis or treatment of the condition, need to be separated or distracted or maintained in a separated condition from one another and then supported in a spaced-apart relationship. Such separation or distraction may be to gain exposure to selected tissue structures, to apply a therapeutic pressure to selected tissues, to return or reposition tissue structures to a more normal or original anatomic position and form, to deliver a drug or growth factor, to alter, influence or deter further growth of select tissues or to carry out other diagnostic or therapeutic procedures. Depending on the condition being treated, the tissue surfaces may be opposed or contiguous and may be bone, skin, soft tissue, or a combination thereof.

One location of the body where tissue separation is useful as a corrective treatment is in the spinal column. Developmental irregularities, trauma, tumors, stress and degenerative wear can cause defects in the spinal column for which surgical intervention is necessary. Some of the more common defects of the spinal column include vertebral compression fractures, degeneration or disruption of an intervertebral disc and intervertebral disc herniation. These and other pathologies of the spine are often treated with implants that can restore vertebral column height, immobilize or fuse adjacent vertebral bones, or function to provide flexibility and restore natural movement of the spinal column. Accordingly, different defects in the spinal column require different types of treatment, and the location and anatomy of the spine that requires corrective surgical procedures determines whether an immobilizing implantable device or a flexible implantable device is used for such treatment.

In a typical spinal corrective procedure involving distraction of tissue layers, damaged spinal tissue is removed or relocated prior to distraction. After the damaged tissue has been removed or relocated, adjacent spinal tissue layers, such as adjacent bone structures, are then distracted to separate and restore the proper distance between the adjacent tissue layers. Once the tissue layers have been separated by the proper distance, an immobilizing or flexible device, depending on the desired treatment, is implanted between the tissue layers. In the past, the implantable treatment devices have been relatively large cage-like devices that require invasive surgical techniques which require relative large incisions into the human spine. Such invasive surgical techniques often disrupt and disturb tissue surrounding the surgical site to the detriment of the patient.

Therefore, there remains a need for implantable treatment devices and methods that utilize minimally invasive procedures.

Such methods and devices may be particularly needed in the area of intervertebral or disc treatment. The intervertebral disc is divided into two distinct regions: the nucleus pulposus and the annulus fibrosus. The nucleus lies at the center of the disc and is surrounded and contained by the annulus. The annulus contains collagen fibers that form concentric lamellae that surround the nucleus and insert into the endplates of the adjacent vertebral bodies to form a reinforced structure. Cartilaginous endplates are located at the interface between the disc and the adjacent vertebral bodies.

The intervertebral disc is the largest avascular structure in the body. The cells of the disc receive nutrients and expel waste by diffusion through the adjacent vascularized endplates. The hygroscopic nature of the proteoglycan matrix secreted by cells of the nucleus operates to generate high intra-nuclear pressure. As the water content in the disc increases, the intra-nuclear pressure increases and the nucleus swells to increase the height of the disc. This swelling places the fibers of the annulus in tension. A normal disc has a height of about 10-15 mm.

There are many causes of disruption or degeneration of the intervertebral disc that can be generally categorized as mechanical, genetic and biochemical. Mechanical damage includes herniation in which a portion of the nucleus pulposus projects through a fissure or tear in the annulus fibrosus. Genetic and biochemical causes can result in changes in the extracellular matrix pattern of the disc and a decrease in biosynthesis of extracellular matrix components by the cells of the disc. Degeneration is a progressive process that usually begins with a decrease in the ability of the extracellular matrix in the central nucleus pulposus to bind water due to reduced proteoglycan content. With a loss of water content, the nucleus becomes desiccated resulting in a decrease in internal disc hydraulic pressure, and ultimately to a loss of disc height. This loss of disc height can cause the annulus to buckle with non-tensile loading and the annular lamellae to delaminate, resulting in annular fissures. Herniation may then occur as rupture leads to protrusion of the nucleus.

Proper disc height is necessary to ensure proper functionality of the intervertebral disc and spinal column. The disc serves several functions, although its primary function is to facilitate mobility of the spine. In addition, the disc provides for load bearing, load transfer and shock absorption between vertebral levels. The weight of the person generates a compressive load on the discs, but this load is not uniform during typical bending movements. During forward flexion, the posterior annular fibers are stretched while the anterior fibers are compressed. In addition, a translocation of the nucleus occurs as the center of gravity of the nucleus shifts away from the center and towards the extended side.

Changes in disc height can have both local and global effects. Decreased disc height results in increased pressure in the nucleus, which can lead to a decrease in cell matrix synthesis and an increase in cell necrosis and apoptosis. In addition, increases in intra-discal pressure create an unfavorable environment for fluid transfer into the disc, which can cause a further decrease in disc height.

Decreased disc height also results in significant changes in the global mechanical stability of the spine. With decreasing height of the disc, the facet joints bear increasing loads and may undergo hypertrophy and degeneration, and may even act as a source of pain over time. Decreased stiffness of the spinal column and increased range of motion resulting from loss of disc height can lead to further instability of the spine, as well as back pain.

Radicular pain may result from a decrease in foraminal volume caused by decreased disc height. Specifically, as disc height decreases, the volume of the foraminal canal, through which the spinal nerve roots pass, decreases. This decrease may lead to spinal nerve impingement, with associated radiating pain and dysfunction.

Finally, adjacent segment loading increases as the disc height decreases at a given level. The discs that must bear additional loading are now susceptible to accelerated degeneration and compromise, which may eventually propagate along the destabilized spinal column.

In spite of all of these detriments that accompany decreases in disc height, where the change in disc height is gradual many of the ill effects may be “tolerable” to the spine and patient and may allow time for the spinal system to adapt to the gradual changes. However, the sudden decrease in disc volume caused by the surgical removal of the disc or disc nucleus may increase the local and global problems noted above.

Many disc defects are treated through a surgical procedure, such as a discectomy in which the nucleus pulposus material is removed. During a total discectomy, a substantial amount (and usually all) of the volume of the nucleus pulposus is removed and immediate loss of disc height and volume can result. Even with a partial discectomy, loss of disc height can ensue. Discectomy alone is the most common spinal surgical treatment, frequently used to treat radicular pain resulting from nerve impingement by disc bulge or disc fragments contacting the spinal neural structures.

The discectomy may be followed by an implant procedure in which a prosthesis is introduced into the cavity left in the disc space when the nucleus material is removed. Thus far, the most common prosthesis is a mechanical device or a “cage” that is sized to restore the proper disc height and is configured for fixation between adjacent vertebrae. These mechanical solutions take on a variety of forms, including solid kidney-shaped implants, hollow blocks filled with bone growth material, push-in implants and threaded cylindrical cages.

A challenge in the use of a posterior procedure to install spinal prosthesis devices is that a device large enough to contact the end plates and expand the space between the end plates of the same or adjacent vertebra must be inserted through a limited space. In the case of procedures to increasing intervertebral spacing, the difficulties are further increased by the presence of posterior osteophytes, which may cause “fish mouthing” or concavity of the posterior end plates and result in very limited access to the disc. A further challenge in degenerative disc spaces is the tendency of the disc space to assume a lenticular shape, which requires a relatively larger implant than often is easily introduced without causing trauma to the nerve roots. The size of rigid devices that may safely be introduced into the disc space is thereby limited.

While cages of the prior art have been generally successful in promoting fusion and approximating proper disc height, typically these cages have been inserted from the posterior approach, and are therefore limited in size by the interval between the nerve roots. Further, it is generally difficult to implant from the posterior approach a cage that accounts for the natural lordotic curve of the lumber spine.

It is desirable to reduce potential trauma to the nerve roots and yet still allow restoration or maintenance of disc space height in procedures involving vertebrae fusion devices and disc replacement, containment of the nucleus of the disc or prevention of herniation of the nucleus of the disc. In general minimally invasive surgical techniques reduce surgical trauma, blood loss and pain. However, despite the use of minimally invasive techniques, the implantation of cage devices for treating the spine typically involves nerve root retraction, an inherently high risk procedure. It is therefore desirable to reduce the degree of invasiveness of the surgical procedures required to implant the device, which may also serve to permit reduction in the pain, trauma, and blood loss as well as the avoidance and/or reduction of the nerve root retraction.

In minimally invasive procedures, to monitor placement, it is useful that implant devices inserted into spinal tissue be detectable using fluoroscopic imaging systems. However if a device is visible using X-ray technology, then the device can interfere with the detection and monitoring of spinal tissues, such as bone growing into the disc space after a vertebral fusion procedure. Additional advances would also be useful in this area.

SUMMARY

There are several aspects of the present subject matter which may be embodied separately or together in the devices and systems described and claimed below. These aspects may be employed alone or in combination with other aspects of the subject matter described herein, and the description of these aspects together is not intended to preclude the use of these aspects separately or the claiming of such aspects separately or in different combinations as set forth in the claims appended hereto.

In one aspect, a tissue distraction device includes first and second elongated members. The first and second elongated members are insertable between tissue layers and adapted to define a structure in situ having a dimensional aspect in a direction extending between the tissue layers. The tissue distraction device also includes an augmenting elongated member insertable between and in contact with the first and second elongated members to spread the first and second elongated members apart to increase the dimensional aspect of at least a portion of the structure in situ. The augmenting, first, and second elongated members are sufficiently flexible to change between a generally linear configuration and a generally less linear configuration. A locking member is configured to be secured to one of the elongated members at a plurality of locations to lock the augmenting, first, and second elongated members in the generally less linear configuration.

In another aspect, a tissue distraction device includes first and second elongated members defining a generally annular configuration. An augmenting member is fully received between the first and second elongated members and having a linear extent less than the linear extents of the first and second elongated members.

In yet another aspect, a method is provided for assembling a structure in vivo between two body tissue layers comprising first and second elongated members, an augmenting elongated member, and a locking member secured to one of the elongated members at a first location. The method includes delivering the first and second elongated members toward a location between two body tissue layers in a generally linear configuration to define at least a portion of a structure having a dimensional aspect in a direction extending generally from one of the body tissue layers to the other body tissue layer. The configurations of the first and second elongated members is changed to a generally less linear configuration. The augmenting elongated member is inserted between and in contact with the first and second elongated members to spread the first and second elongated members apart to increase the dimensional aspect of at least a portion of the structure. The locking member is secured to one of the elongated members at a second location to lock the first and second elongated members in the generally less linear configuration.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a perspective view of a distraction device or support structure according to the present disclosure;

FIG. 1A is a side elevational view of a distraction device or support structure according to the present disclosure having a non-uniform thickness;

FIG. 2 is a perspective view of the distraction device of FIG. 1, deployed within a vertebral disc space;

FIG. 3 is a top plan view of the lower elongated member of the distraction device of FIG. 1;

FIG. 4 is a perspective view of an augmenting member of the distraction device of FIG. 1;

FIGS. 5-7 are perspective views of a proximal end portion of the upper elongated member of the distraction device of FIG. 1, with an associated anchor member being shown in different positions;

FIG. 8 is an end view of the two elongated members and the augmenting member of the distraction device of FIG. 1, in a disassembled condition;

FIG. 9 is an end view of the two elongated members and augmenting member of FIG. 8, in an assembled condition;

FIG. 10 is a side view of proximal ends of the two elongated members and augmenting member of FIG. 8, in a partially assembled condition;

FIG. 11 is a side view of proximal ends of the two elongated members and augmenting member of FIG. 8, in an assembled condition;

FIG. 12 is a top plan view of the elongated members of the distraction device of FIG. 1 at least partially positioned within a deployment cannula;

FIG. 13 is an end view of the elongated members and cannula of FIG. 12;

FIG. 14 is a cross-sectional top plan view of the augmenting elongated member of the distraction device of FIG. 1;

FIG. 15 is an end view of the distraction device of FIG. 1, with a locking member thereof in an unlocked condition;

FIG. 16 is an end view of the distraction device of FIG. 1, with a locking member thereof in a locked condition;

FIG. 17 is a cross-sectional top plan view of a proximal end of the augmenting elongated member of the distraction device of FIG. 1, with a locking member thereof in an initial condition;

FIG. 18 is a cross-sectional top plan view of a proximal end of the augmenting elongated member of the distraction device of FIG. 1, with a locking member thereof in a locked condition;

FIG. 19 is perspective view of a delivery device suitable for delivering the distraction device of claim 1 to a work space;

FIG. 20 is a cross-sectional view of the delivery device of FIG. 19;

FIG. 21 is a perspective view of a shearing assembly of the delivery device of FIG. 19;

FIG. 22 is a perspective view of a pusher device suitable for use with the delivery device of FIG. 19;

FIG. 23 is a perspective view of an extraction device suitable for use with the delivery device of FIG. 19;

FIGS. 24 and 25 are perspective views of disc space sizing devices for determining the proper distraction device to deploy to a vertebral disc space;

FIG. 26 is a perspective view of a funnel for use in delivering a bone filler material to the open interior of the distraction device of FIG. 1;

FIG. 27 is a perspective view of a tamp for use in combination with the funnel of FIG. 26;

FIGS. 28-33 are perspective views illustrating a method of deploying the distraction device of FIG. 1 to a disc space;

FIG. 34 is a top plan view of an alternative embodiment of an elongated member or distraction device according to the present disclosure;

FIG. 35 is a top plan view of the elongated member or distraction device of FIG. 34, with a fixture or fastener securing the proximal and distal ends of the elongated member or distraction device;

FIG. 36 is a perspective view of a distraction device having an elongated member with shape memory properties;

FIG. 37 is a top plan view of an elongated member or distraction device configured to maintain a generally annular configuration without a separate locking member or fastener or fixture; and

FIG. 38 is a top plan view of the elongated member or distraction device of FIG. 37, in a generally annular configuration.

 DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS

The embodiments disclosed herein are for the purpose of providing a description of the present subject matter, and it is understood that the subject matter may be embodied in various other forms and combinations not shown in detail. Therefore, specific embodiments and features disclosed herein are not to be interpreted as limiting the subject matter as defined in the accompanying claims.

The devices and methods of the present invention provide multiple features of distraction devices, distraction device support structures and deployment systems that can be used to actively separate tissue layers by engaging them and forcing them apart, or to support the separation of tissue layers separated by the distraction device itself or by other devices or processes or a combination of these.

As used herein, the terms “distraction device” and “support structure” are intended to have a general meaning and is not limited to devices that only actively separate tissue layers, only support tissue layers or only both actively separate and support tissue layers. For example, the distraction device and support structure in general can be used to actively separate layers of tissue and then be removed after such separation, or the distraction device and the support structure could be used to support layers of tissue that have been previously separated by a different device. Alternatively, the distraction device and support structure can be used to actively separate the layers of tissue and remain in place to support the layers of tissue in order to maintain such separation. Unless more specifically set forth in the claims, as used herein, “distraction device” and “support structure” encompass any and all of these. In addition, it should be noted that the references to “first” and “second” members or devices are for convenience in the written description. They may be combined to provide a single distraction assembly or structure of selected distraction height, and the assembly is not limited to any particular number of “devices” or “members.” In keeping with the broader aspects of the present invention the specific number of “devices” or “members” can be varied according to the intended usage or design considerations.

It should also be understood that various embodiments of the device, system and method of the present invention are illustrated for purposes of explanation in vertebral fusion procedures and/or replacement of removed discs. However, in its broader aspects, the various features of the present invention are not limited to these particular applications and may be used in connection with other tissue layers, such as soft tissue layers, although it has particular utility and benefit in treatment of vertebral conditions within intervertebral discs or disc spaces.

One embodiment of a distraction device or support structure or implant 10 is shown in FIGS. 1 and 2. The distraction device 10 shown in FIGS. 1 and 2 is comprised of a first or lower elongated member 12, a second or upper elongated member 14, an augmenting elongated member 16, and a locking member 18. The augmenting elongated member 16 cooperatively interacts with the first and second elongated members 12 and 14 to increase a dimensional aspect of the distraction device or support structure 10. The distraction device 10 is preferably comprised of elongated members made of biocompatible materials (including metals and polymers) that are suitable for long term implantation into human tissue where treatment is needed. The biocompatible materials may, for example, be calcium phosphate, tricalcium phosphate, hydroxyapatite, polyetheretherketone (PEEK), nylon, Nitinol (NiTi) or any other suitable biocompatible material. Suitable biocompatible material may also include PEEK with carbon fibers, polyethylenes of low, medium and or high densities, as well as nylons and blends of materials that contain nylons. It is also within the scope of the present disclosure for the elongated members to be at least partially comprised of one or more bioabsorbable materials, such as polyglycolic acid (PGA) or poly-L lactic acid (PLLA), for example. To the extent not contradicted by the present disclosure, elongated members according to the present disclosure may be manufactured, configured, and function generally according to the disclosure of U.S. Patent Application Publication No. 2008/0234687 to Schaller et al., which is incorporated herein by reference.

Elongated members according to the present disclosure may be manufactured using a number of techniques, including machining or milling techniques. Milling can include cutting elongated members from solid blocks or rods of PEEK or other suitable material. Elongated members may also be manufactured using molding techniques. Molding techniques include co-molding various materials together to form an elongated member, as well as molding a second material over a first material. Elongated members may also be manufactured by injection molding or extrusion processes. In addition, the elongated members of the present invention may be manufactured with electrical discharge machining processes and by rapid prototyping methods including fused deposition modeling (FDM) and stereo lithography (SLA) techniques.

Preferably, the elongated members which form the distraction device 10 have a generally linear configuration for insertion into tissue or between tissue layers. FIG. 3 shows the first or lower elongated member 12 in a generally linear configuration (with the understanding that the second or upper elongated member 14 may be substantially identical to or a mirror image of the first elongated member 12) and FIG. 4 shows the augmenting elongated member 16 in a generally linear configuration. The distal ends of the elongated members can have chamfer or incline or wedge features to ease the passage of the elongated member through tissue such as bone or vertebral disc material. For example, FIGS. 1 and 2 show a chamfer or incline feature 20 visible on the upper surface 22 of the distal end 24 of the second elongated element 14. It should be understood that the lower surface 26 of the distal end 28 of the first elongated element 12 may include a similar chamfer feature.

When deployed into or between tissue, the elongated members change configuration, preferably by flexing or bending, to a generally less linear configuration to define the distraction device or support structure 10. In a preferred embodiment, which is shown in FIGS. 1 and 2, the distraction device 10 is generally annular, with the first and second elongated members 12 and 14 also being generally annular and the augmenting elongated member 16 being generally arcuate, but non-annular, as will be described in greater detail herein. The elongated members of the distraction device 10 may include features that add flexibility to the elongated member to assist in bending or changing the configuration of the elongated member from a generally linear configuration to a less linear configuration and vice versa. For example, the elongated members may include lateral teeth 30 and intermediate slots or indents 32 (FIGS. 3 and 4) that aid in relieving stress and add flexibility to the elongated member. When the elongated member is deployed in spinal tissue, the slots 32 may also provide gaps for the introduction of bone graft materials, cements, or pharmaceutical compounds to the spinal tissues.

In some embodiments, the elongated members may also be designed with additional features that limit or control the nature of the bending or shape change that the elongated members may experience. For example, FIGS. 3 and 4 show a plurality of T-shaped members 34 on one lateral side of the elongated member (i.e., the lateral side opposite the aforementioned teeth 30 and slots 32, if provided), with the T-shaped members 34 having longitudinal extensions on their outer edge such that adjacent T-shaped members 34 almost touch each other, leaving a relatively narrow opening or aperture 36 at a more central location between adjacent T-shaped members 34. When the elongated member is bent toward the lateral side having the T-shaped members 34, the longitudinal extensions on adjacent T-shaped members 34 come into contact and provide resistance to further bending, thereby acting as a stop to limit further curvature. In contrast, the teeth 30 on the opposite lateral side of the elongated member lack such longitudinal projections and, therefore, the elongated member can be bent to a much greater degree in this direction before the teeth 30 come into contact with adjacent teeth 30 to limit further curvature. Also, it should be noted that by providing the T-shaped members 34 and intermediate opening or apertures 36, increased flexibility is provided that allows the elongated member to bend toward the opposite side (i.e., upwardly in the orientation of FIG. 3 or to the right in the orientation of FIG. 4).

Additional features may be added to enhance or limit the flexibility of the elongated members of the distraction devices, including grooves, slots, channels, and pockets and teeth or other extensions or members of various shapes. The slots, grooves, channels, and pockets may be placed, for example, in a linear pattern or spirally around the body of the elongated member. Through holes or apertures may also assist in providing flexibility as well as serve as lumens for various wires or filaments, as will be discussed in greater detail. The placement of a greater number of these features in one region of an elongated member can make that region more or less flexible than other regions of the device with fewer or different flexibility enhancing or limiting features. In this manner, selected regions of the elongated member will be easier or more difficult to bend or deflect to assist the shaping of the distraction device 10 in a desired configuration, such as a circular, rectangular, or oval shape. Alternatively, the flexibility features can be located uniformly along a segment or the whole of the elongated member to provide regions of uniform flexibility.

Flexibility of the elongated members may also be achieved or varied by fabricating the device from a combination of materials with different degrees of flexibility. For instance, by located more rigid material on one side of an elongated member, the elongated member may be easier to bend or deflect toward that side. Particularly, if the elongated member is preformed into a desired in situ configuration (e.g., a curved configuration) and temporarily straightened for insertion, the more rigid material may tend to retain the desired configuration to a greater degree than the other material and form the desired configuration when the elongated member is introduced into the work space. Also, the elongated member can have alternating or different sections along its length that are made of different materials having different rigidity.

In another aspect of the present disclosure, the elongated members preferably have the ability to recover from temporary deformation. As noted previously, the elongated member(s) may be pre-set or pre-formed into a desired in situ shape and then temporarily reshaped, such as by straightening, for insertion. In this aspect, for instance, a pre-shaped elongated member may tend to recover its shape more quickly or completely in body-temperature spinal tissue after being in a less-curved condition during shipping and storage inside of a deployment cannula. In other embodiments, due to plastic creep or other material characteristics, the elongated members may not recover their original shape after extended deformation in the cannula, and an external force may be used to shape the elongated member after it is at least partially inserted into the work space.

In a specific example, elongated members manufactured from polymeric materials such as PEEK may be pre-shaped by placing the elongated member in a metal fixture or jig having a desired shape, such as an annular or arcuate shape, and then heating the elongated member to relieve the bending stress. For instance, the elongated member can be treated for about 5 minutes at about 160° C. For many polymeric materials, such as PEEK, the pre-shaping process biases the elongated member toward a desired shape yet still allows the elongated member to be deformed either in the cannula or in situ after the elongated member is inserted into a work space. In some embodiments, such as where the elongated members are comprised at least in part of PEEK, the elongated members do not have shape memory material properties. Consequently, in some embodiments, particularly when PEEK is used, the elongated member does not return to its original shape without the additional application of an external force to shape the member. Such external force may be applied, for example, by a pull wire, as will be described in more detail.

In some embodiments, the deformation of the elongated members is constrained in a first axis and allowed in a plane at an angle to the first axis to allow deflection in a different plane. For instance, in FIG. 2, a generally annular distraction device 10 is shown in a vertebral disc. As used herein, the term “annular” is not limited to substantially circular distraction devices and elongated members, but may include other closed shapes, such as ovals and rectangles, or substantially closed versions of such shapes. The distraction device 10 is formed by the aforementioned three elongated members 12, 14, and 16 and is relatively rigid in the direction (e.g., a vertical direction when standing) extending between two tissues layers, i.e. the adjacent vertebra. The distraction device 10 is resistant to deflection in a direction parallel to the longitudinal axis of the spine due to the relatively solid, continuous structure of the elongated members along this axis. Consequently, due to the structure of the elongated members forming the distraction device 10 of FIG. 2, no deflection or only limited deflection is allowed in the direction of distraction. In certain embodiments, the distraction device or implant 10 does not substantially compress under vertical forces that the human spine normally endures, such as, but not limited to, up to about 1000 N. In contrast, the elongated members are relatively more flexible in the plane perpendicular to the direction of distraction to allow the elongated members to be shaped as desired, such as curved or deflected to conform to the shape of the space into which they are implanted.

Looking more particularly at the augmenting elongated member 16, it is configured to be inserted and slid between the first and second elongated members 12 and 14 to increase the height of or otherwise augment the distraction device 10. The degree of height increase of the distraction device 10 is dependent upon the height of the augmenting elongated member 16. For instance, a thicker augmenting elongated member (i.e., an augmenting elongated member having a relatively great height) will cause a greater increase in the height of the distraction device than a thinner augmenting elongated member (i.e., an augmenting elongated member having a relatively small height). In embodiments inserted into the disc space to distract adjacent vertebral bodies, the height of the distraction device 10 (which is generally equal to the combined heights of the bodies of the constituent elongated members) is preferably sufficient to restore the disc to its normal height or thereabout, which will depend on the size of the patient and the disc's location in the spinal column. The height of the distraction device 10 can be, for example, from about 5 mm to about 15 mm. More particularly, the height can be from about 7.5 mm to about 13.5 mm, or about 9 mm to about 12 mm and ranges therein. For relatively short individuals or children, the disc size and, consequently, the height of the support structure can be, for example, from about 5 mm to about 7 mm. For relatively tall individuals, the disc height and, consequently, the height of the support structure can be, for example, from about 9 mm to about 15 mm or greater potentially. In other applications, the dimensions (including the heights) of the individual elongated members and the resulting distraction device may vary without departing from the scope of the present disclosure.

In one embodiment, the thickness of the augmenting elongated member can be different along its length to cause different amounts of additional distraction along the length of the distraction device. For instance, the proximal portion of the augmenting member may be thicker (taller) than the distal portion of the augmenting member, in which case the increase in the height of the proximal portion of the distraction device will be greater than the augmentation in the height of the distal portion of the device. The ability to create a greater increase in height in one region of a distraction device allows for adjustments in the curvature of the spine of a patient. For instance, a collapsed disc in the lumbar region of the spine can result in the loss of the normal lordosis in the lumbar region of the spine. The insertion of an augmenting elongated member of variable thickness/height between upper and lower elongated members deployed in a collapsed lumbar disc can restore the lumbar disc to the more normal morphology of a greater height on its anterior region as compared to its posterior region. In such a situation, the augmenting member may have a greater height at its central region between the distal and proximal ends than at either the proximal end or distal end. FIG. 1A illustrates an exemplary distraction device 10A having a non-uniform thickness.

Preferably, once augmented, the height of the distraction device 10 is fixed and is not adjustable or variable, while the augmenting member 16 is preferably fixed in position between the first and second elongated members 12 and 14 and not removable. The first and second elongated members 12 and 14 may have corresponding contoured surfaces or features that mechanically or frictionally cooperate or mate to assist in maintaining the positions of the first and second elongated members 12 and 14 relative to each other and within a work space to increase the stability of the distraction device 10. For example, in one embodiment, the upper surface 22 of the second elongated element 14 (as shown in greater detail in FIGS. 5-7) and the lower surface 26 of the first elongated element 12 include protrusions or ribs or teeth 38 or is otherwise textured, which may be advantageous when the first and second elongated members 12 and 14 are in their generally less linear configuration to define the distraction device 10. In particular, such textured surfaces may be advantageous in that contact between the protrusions 38 and the tissue to be distracted and/or supported may help to anchor the elongated member (and, hence, the distraction device 10) in position. For example, when the distraction device 10 contacts a vertebral body, the protrusions 38 may dig into the vertebral body for improved traction, thereby decreasing the risk of movement of the distraction device 10 after implantation.

The top side or surface 40 of the first elongated member 12 may contain a contoured portion 42 (FIGS. 3, 8, and 9), while the bottom side or surface 44 of the second elongated member 14 may also include a contoured portion 46, as shown in FIGS. 8 and 9. The augmenting elongated member 16 also may include a bottom contoured portion or surface 48 and a top contoured portion or surface 50, as shown in FIGS. 4, 8, and 9. In the illustrated embodiment, the contoured portions 48 and 50 of the augmenting elongated member 16 are protrusions or raised ribs that are configured to mate with the contoured portions 42 and 46, respectively, of the first and second elongated members 12 and 14. In the illustrated embodiment, the contoured portions 42 and 46 of the first and second elongated members 12 and 14 are indentations or slots or grooves in the top surface 40 of the first elongated member 12 and the bottom surface 44 of the second elongated member 14. Alternatively, the bottom and top surfaces of the augmenting elongated member may include indentations or slots or grooves that are configured to mate with a protrusion or rib on the top surface of the first elongated member and the bottom surface of the second elongated member, respectively.

As shown in FIGS. 8 and 9, the cooperation between the raised ribs and grooves in the facing surfaces between of the elongated members also can function as a guide or guide track that directs the augmenting elongated member 16 between the first and second elongated members 12 and 14. As seen in FIGS. 10 and 11, the proximal ends 52 and 54 of the first and second elongated members 12 and 14 can also be ramped or widened to provide a larger opening, thereby easing the entry of the augmenting elongated member 16 (which may have a tapered or wedge-shaped distal end 56, as noted above) between the first and second elongated members 12 and 14. Furthermore, any of the elongated members may have additional mating or guiding surfaces which provide added stability to the resulting distraction device or implant support structure 10.

In a preferred embodiment, the raised ribs 48 and 50 and grooves 42 and 46 are configured to prevent vertical separation of the elongated members. For example, the illustrated raised ribs 48 and 50 are generally T-shaped, while the grooves 42 and 46 have relatively narrow necked-down portions 58. As the augmenting elongated member 16 is inserted between the first and second elongated members 12 and 14, the relatively wide heads 60 of the raised ribs 48 and 50 are received by the grooves 42 and 46, with the necked-down portions 58 positioned between the wide heads 60 and the body of the augmenting elongated member 16. By such a configuration, the rib heads 60 and the necked-down portions 58 of the grooves 42 and 46 prevent the elongated members from being vertically separated after at least partial insertion of the augmenting elongated member 16 between the first and second elongated members 12 and 14. This locking mechanism may assist in preventing the elongated members from slipping relative to one another in response to the stresses a patient's normal movements place on the implant 10.

FIGS. 10 and 11 also show another optional locking feature for securing the elongated members together. In the illustrated embodiment, the first and second elongated members 12 and 14 include recesses 62 into which locking protrusions 64 of the augmenting member 16 can enter to lock the augmenting member 16 into a desired longitudinal orientation relative to the first and second elongated members 12 and 14. When fully engaged, all three elongated members are substantially locked against relative movement. Preferably, the locking protrusions 64 enter into the recesses 62 to lock the elongated members together when the augmenting elongated member 16 has been fully inserted between the other two elongated members 12 and 14, but it is also within the scope of the present disclosure for the elongated members to lock together prior to the augmenting elongated member 16 being fully received between the other two elongated members 12 and 14. For example, the elongated members may be configured such that the augmenting elongated member 16 is not advanced fully into the space between the other two elongated members 12 and 14, but is instead locked in place with a portion (e.g., a proximal end) remaining outside of the space between the other two elongated members 12 and 14.

The guiding of the locking protrusions 64 into the recesses 62 may be assisted by locating them along the contoured surfaces of the associated elongated member. As seen in FIGS. 3 and 4, for example, the recess 62 and groove 42 in the upper surface 40 of the first elongated member 12 are aligned, thereby allowing the groove 42 to act as a guide in which the locking protrusion 48 on the bottom surface 66 of the augmenting elongated member 16 slides distally to seat within the recess 62, as shown in FIG. 11. FIG. 4 shows how the protrusion 64 and raised rib 50 of the upper surface 68 of the augmenting elongated member 16 are similarly aligned, as may be the protrusion 64 and raised rib 48 of the lower surface 66 of the augmenting elongated member 16.

As illustrated, the locking protrusions 64 may be cylindrically shaped, but it may be otherwise shaped without departing from the scope of the present disclosure. If provided as a cylinder, the diameter of the locking protrusion 64 may be greater than the width of the associated raised rib 48, 50 (FIG. 4) and of the associated groove 42, 46 at the point 70 it meets the recess 62 into which the protrusion 64 is to be seated (FIG. 3). By such a configuration, the protrusion 64 may be pressed into the recess 62, but will resist being retracted therefrom due to the relatively narrow entry point 70. The portion 72 of the groove 42, 46 immediately distal the recess 62 may also be relatively narrow, thereby preventing over-advancement of the protrusion 64 beyond the recess 62.

The locking protrusions 64 may be any suitable size or material, such as cylinders or pins made of a radiopaque material (e.g., tantalum or gold or platinum) with a diameter ranging from about 0.25 mm to about 2 mm. By providing the locking protrusions 64 as radiopaque members, they assist the surgeon in positioning the elongated members in situ. For a similar effect, the interlocking recesses 62 may be lined with tantalum or another radiopaque material. In other embodiments, other portions of the elongated members may be radiopaque to further assist in determining the locations of the elongated members in situ. In one exemplary embodiment, the elongated members are manufactured from radiolucent materials, such as PEEK (which may be a preferred material), polyetherketoneketone (PEKK), nylon and ultrahigh molecular weight polyethylenes (UMPE). By providing discrete radiopaque regions or markers in known locations within the elongated members, the surgeon may determine the locations and relative orientations of the elongated members in situ.

In addition to the foregoing features, the elongated members may further include internal cavities or passages or lumen for receiving various wires or filaments. For example, as described above, the shape of the distraction device 10 may be assisted, controlled, and/or adjusted as the elongated members are being deployed between the tissues to be distracted. The forces required to control the shape of the elongated members are preferably compatible with typical hand-held delivery systems and tools. For instance, the shape of an elongated member may be controlled with pull wire systems deployed either inside the elongated member and/or outside the elongated member. In the illustrated embodiment, the shape of the first and second elongated members 12 and 14 is controlled during insertion by applying a greater force to one side of the elongated members than is applied to the other side using a pull wire 74 (FIGS. 12 and 13). The application of unequal force causes the elongated members 12 and 14 to curve in a particular direction (i.e., to the left in the orientation of FIG. 12).

In the embodiment of FIGS. 12 and 13, the pull wire 74 passes through both the first and second elongated members 12 and 14. The pull wire 74 may pass through a wire lumen 76, 78 of each of the first and second elongated members 12 and 14 like those shown in FIGS. 8 and 9 or, alternatively, through a wire channel or slot that is not fully enclosed. As shown in FIG. 13, the pull wire 74 passes out of the distal end of one wire lumen, and then loops back into the other wire lumen. The pull wire 74 may be a single wire or filament or a braid or weave comprising multiple wires or filaments and may be made of any flexible material that can be used to exert a force along the length of the first and second elongated members 12 and 14, such as steel, Nitinol, fiber (both synthetic and natural), or the like. In the illustrated example shown in FIGS. 8, 9, 12, and 13, the pull wire 74 is on the left side of the first and second elongated members 12 and 14 (when considered from the proximal ends of the elongated members) such that a proximally directed force (e.g., pulling one or both of the ends of the wire 74, will cause the first and second elongated members 12 and 14 to curve to the left. Alternatively, systems in which a push or a distally directed force, applied through a rigid pusher or the like could be provided to the first and second elongated members 12 and 14 to cause them to curve in a desired direction.

In systems such as the one illustrated in FIGS. 12 and 13, which include a pull wire 74 that passes through both the first and second elongated members 12 and 14, the pull wire 74 also tends to prevent the first and second members 12 and 14 from separating during deployment into the work space. In particular, a pull wire 74 extending through both the first and second elongated members 12 and 14 may also allow pull force to be exerted to maintain the position of the first and second elongated members 12 and 14 adjacent to the distal end 80 of a deployment cannula 82 while the augmenting member 16, is being inserted between the first and second elongated members 12 and 14. In particular, the insertion of the augmenting elongated member 16 between the first and second elongated members 12 and 14 can create a repulsive force that tends to push the first and second elongated members 12 and 14 away from both the cannula 82 and the augmenting member 16. The force exerted by the pull wire 74 and the force of friction between the surfaces of the first and second elongated members 12 and 14 and the surrounding tissues, such as the endplates of the vertebrae above and below a disc, can also serve to resist this repulsive force.

In other embodiments, including the illustrated embodiment, a separate mechanism may be provided to maintain the position of the first and second elongated members 12 and 14 with respect to the deployment cannula 82 while the augmenting elongated member 16 is inserted therebetween. As shown in FIGS. 5-7 and 12, an anchoring or tethering system or wires 84 can be used to hold the first and second elongated members 12 and 14 aligned with the distal end 80 of the delivery cannula 82 while the augmenting elongated member 16 is inserted between the first and second elongated members 12 and 14. The illustrated tethering system includes a pair of anchor wires or cables or filaments 84, each of which attaches to the proximal end region 52, 54 of one of the first and second elongated members 12 and 14. As best shown in FIGS. 5-7, each anchor wire 84 may include an enlarged end 88 (e.g., a generally spherical or ball-shaped end piece) that is at least partially received within a cavity 90 defined within the proximal end 52, 54 of the associated elongated member (FIG. 5). The thinner proximal or body portion of the anchor wire 84 extends through a retaining hole 92 (FIGS. 6 and 7) communicating with the cavity 90 while the enlarged end 88 is positioned within the cavity 90. The diameter of each retaining hole 92 is smaller than that of the associated enlarged end 88 to resist removal of the enlarged end 88 from the cavity 90 in a proximal direction.

The anchor wires 84 may provide little resistance to the deployment of the first and second elongated members 12 and 14, permitting the first and second elongated members 12 and 14 to exit the distal end 80 of the deployment cannula 82. The length and tension of the anchor wires 84 are adjustable to provide increased tension after the first and second elongated members 12 and 14 have exited the cannula 82. The anchor wires 84 keep the first and second elongated members 12 and 14 in close proximity to the distal end 80 of the cannula 82, thereby allowing the insertion of the augmenting elongated member 16 between the first and second elongated members 12 and 14 without having to increase the tension on the pull wire 74. This may be advantageous, as applying excessive tension to the pull wire 74 may move the first and second elongated members 12 and 14 to an undesirable curved configuration during insertion of the augmenting elongated member 16 therebetween.

After the implant 10 has been deployed and properly positioned, the anchor wires 84 may be detached from the first and second elongated members 12 and 14. In one embodiment, after the pull wire 84 has been removed from the implant 10 (e.g., by cutting it and applying a proximally directed force to both of its ends), a distally directed force may be applied to the implant 10 (e.g., pushing the implant 10 approximately 2 mm further from its deployed position) while the tension in the anchor wires 84 is maintained. Doing so effectively increases the tension on the anchor wires 84, which increased tension will cause the enlarged ends 88 of the anchor wires 84 to enter (FIG. 6) and pull through (FIG. 7) the smaller retaining holes 92 in the elongated members, thereby detaching the anchor wires 84 from the implant 10. Alternatively, a looped anchor wire (or wires) may be formed, such that a loop passes through holes or slots or openings in both of the first and second elongated members 12 and 14. The loop may then be cut by the user or break automatically like a mechanical fuse at the completion of insertion by the user cutting or otherwise severing the loop. In another embodiment, the loop may be configured to pull through or to cut through portions of the first and second elongated members 12 and 14 to detach without the loop being cut or severed.

As shown in FIG. 13, when the augmenting member 16 is positioned within the cannula 82, the pull wire 74 and anchor wires 84 may extend proximally beyond the augmenting elongated member 16 by occupying the space between the corners of the augmenting elongated member 16 and the corners of the cannula 82.

As noted above, the augmenting elongated member 16 may include a locking feature or mechanism or member in the form of a locking wire or cable or tether or filament 18, which is illustrated in FIGS. 12-18. The locking member 18 extends between a fixed end 94 (FIGS. 14, 17, and 18) and a free end 96. The fixed end 94 (which may be an enlarged ball or sphere) is secured at or adjacent to the proximal end 98 of the augmenting elongated member 16, positioned within an interior cavity or pocket 100 defined in the augmenting elongated member 16 at or adjacent to its proximal end 98. The interior cavity 100 may also receive a spacer or backstop 102, which will be described in greater detail herein.

An interior passage or lumen or cavity 104 communicates with the interior cavity 100, with the locking member 18 extending distally from the fixed end 94 through the interior passage 104. The interior passage 104 leads to the distal end 56 of the augmenting elongated member 16, where the locking member 18 exits the augmenting elongated member 16 and loops back toward the proximal end 98 of the augmenting elongated member 16, as shown in FIG. 12. The lateral side of the augmenting elongated member 16 includes a lateral groove 106 (best seen in FIG. 18) through which the locking member 18 extends as it loops back toward the proximal end 98 of the augmenting elongated member 16. The lateral groove 106 is located on the side of the augmenting elongated member 16 that will face radially inwardly when the distraction device 10 is fully deployed, such that the lateral groove 106 and the portion of the locking member 18 positioned therein communicate with the open interior or resident volume 108 defined by the generally annular distraction device 10.

At or adjacent to the proximal end 98 of the augmenting elongated member 16, the locking member 18 reenters the interior of the augmenting elongated member 16 from the lateral groove 106 via a bore 110 extending from one lateral side of the augmenting elongated member 16 toward the other lateral side, as shown in FIG. 17. As shown in FIG. 17, the bore 110 may extend all the way between the two lateral sides of the augmenting elongated member 16, but it is also within the scope of the present disclosure for the bore 110 to extend only partially through the width of the augmenting elongated member 16.

In the illustrated embodiment, the bore 110 causes the locking member 18 to reenter the interior cavity 100 of the augmenting elongated member 16 in a region directly adjacent to the spacer 102, but separated from the fixed end 94 of the locking member 18 by the spacer 102. This portion of the locking member 18 extends along the width of the spacer 102 until it reaches a longitudinally extending bore 112 that communicates with the laterally extending bore 110, as best shown in FIG. 18. The free end 96 of the locking member 18 extends through the longitudinally extending bore 112 and exits the proximal end 98 of the augmenting elongated member 16 (FIG. 17), where it is accessible to apply tension to the locking member 18. For example, FIG. 15 shows the locking member 18 in an un-tensioned or moderately tensioned condition, while FIG. 16 shows the locking member 18 in a tensioned condition, with a pulling force applied to the portion of the free end 96 of the locking member 18 extending proximally out of the longitudinally extending bore 112. Applying tension to the free end 96 of the locking member 18 also causes the locking member 18 to separate from the lateral groove 106 and move through the open interior or resident volume 108 of the distraction device 10, as can be understood by comparing FIG. 17 to FIGS. 14 and 18.

The proximal end 98 of the illustrated augmenting elongated member 16 also includes a fastener 114 (e.g., a set screw) positioned within a longitudinal fastener bore 116 in communication with the spacer 102, with a portion of the free end 96 of the locking member 18 positioned between the fastener 114 and the spacer 102. The fastener 114 extends between an outer end 118 and an inner end 120 (FIGS. 17 and 18). The outer end 118 is configured to allow advancement of the fastener 114 in a distal direction into the fastener bore 116 toward the spacer 102. In a preferred embodiment, the outer perimeter of the fastener 114 and the surface of the fastener bore 116 include matching threads, in which case the outer end 118 of the fastener 114 is configured to accept a torque delivery tool or driver that rotates the fastener 114 to advance it distally into the fastener bore 116. In other embodiments, the fastener 114 may be advanced into the fastener bore 116 by non-rotational movement.

The inner end 120 of the fastener 114 is configured to have a cutting or shearing surface that severs the locking member 18 when brought into contact therewith with sufficient force. In the illustrated embodiment, the spacer 102 includes a retaining surface 122 and a cutting surface 124 facing the fastener 114 and separated by a step, with the cutting surface 124 positioned adjacent to and proximal of the retaining surface 122 (i.e., closer to the fastener 114), as shown in FIGS. 17 and 18. When the fastener 114 is sufficiently advanced into the fastener bore 116 (preferably, when it has been fully advanced into the fastener bore 116, which may be one full rotation when the fastener 114 is a threaded set screw), the inner end 120 of the fastener 114 comes into contact with the cutting surface 124 of the spacer 102, thereby severing the extra slack of the locking member 18 therebetween (FIG. 18) while maintaining the tension of the locking member 18. In contrast, the inner end 120 of the fastener 114 remains spaced away from the retaining surface 122 of the spacer 102, but sufficiently close so as to press the locking member 18 against the retaining surface 122, thereby effectively securing the locking member 18 to the spacer 102 of the augmenting elongated member 16 at that location.

By so securing the locking member 18 to the augmenting elongated member 16 at two locations (both of which are at or adjacent to the proximal end 98 of the augmenting elongated member 16 in the illustrated embodiment), the locking member 18 prevents the configuration of the augmenting elongated member 16 from changing. Locking the augmenting elongated member 16 into a particular configuration also effectively locks the first and second elongated members 12 and 14 (as well as the distraction device 10) into their current configuration, due to the locking relationship between the various elongated members, as described above. Preferably, the distraction device 10 is shaped into its final configuration prior to the fastener 114 locking the locking member 18 in place, thereby locking the distraction device 10 in its final configuration for long-term residence within the work space, as will be described in greater detail herein.

While the locking member 18 is described and illustrated as being associated with and secured to the augmenting elongated member 16, it should be understood that the locking member 18 may be associated with one of the other elongated members 12 and 14 and secured to multiple locations of either to lock the distraction device 10 in a particular configuration. Furthermore, it is also within the scope of the present disclosure for a plurality of similarly or differently configured locking members to be provided and associated with one or more of the elongated members. Additionally, rather than the locking member 18 being secured at multiple locations to an individual elongated member, it is also within the scope of the present disclosure for the locking member 18 to be secured at one location of one of the elongated members and at a second location of one of the other elongated members. For example, the locking member 18 may be secured to the augmenting elongated member 16 at a fixed end 94 and extend from the proximal end 98 of the augmenting elongated member 16 to exit the distal end 56 of the augmenting elongated member 16, as described above. After exiting the distal end 56 of the augmenting elongated member 16, the free end 96 of the locking member 18 may be secured to one of the other elongated members by any suitable means, rather than being secured at a second location of the augmenting elongated member 16. It should be understood that so securing the locking member 18 at separate locations of different elongated members will have a similar effect to securing the locking member 18 to separate locations of the same elongated member, in that the resulting distraction device 10 will be locked into a particular configuration.

The wires or cables or filaments or tethers described herein may consist of materials suitable for sterilization and compatible for temporary contact with animal, including human tissue. Metal wires may be made from stainless steel, Nitinol, or other suitable metal wires, for example. Non-metal wires may be made from natural fibers and polymeric fibers including polyethylene, UHPE, Victrex, PET, or similar medical-grade polymers.

Tensile forces may be applied to the wires or cables or filaments or lines described herein by any suitable source. In a preferred embodiment, the tensile forces are applied via a delivery device 126 (FIGS. 19 and 20), of which the deployment cannula 82 is the distal end. To the extent not contradicted by the present disclosure, delivery devices according to the present disclosure may be manufactured and configured generally according to the disclosure of U.S. Patent Application Publication No. 2008/0234687 to Schaller et al., which is incorporated herein by reference.

In the illustrated embodiment, the free ends of the various lines pass through the deployment cannula 82 to be attached to various attachment points located within the delivery device 126. The lines may be attached to the delivery device 126 by any of a number of suitable means, including releasable mechanical features such as screws, clamps, crimps, and ferrules and other like means. The lines may also be attached by knotting, gluing or pinching them to the delivery device 126.

In the illustrated embodiment, the pull wire 74 is associated with a slider 128 that is received within a central opening or cavity 130 of the delivery device 126 that is substantially coaxial with the deployment cannula 82. The slider 128 is movable along the longitudinal axis of the delivery device 126 within the central cavity 130 to adjust the tension in the pull wire 74, thereby adjusting the curvature of the first and second elongated members 12 and 14, as described above. In the illustrated embodiment, the outer surface of the slider 128 is threaded to engage threads of the central cavity 130, such that rotation of the slider 128 about its central axis will advance it proximally and distally through the central cavity 130. It is also within the scope of the present disclosure for the slider 128 to move with respect to the remainder of the delivery device 126 without rotating (e.g., by translational movement). If the slider 128 is configured to rotate while moving through the central cavity 130, an insertion knob 132 may be associated with the slider 128 and extend outside of the central cavity 130 to be rotated in order to rotate and move the slider 128 through the central cavity 130.

In the illustrated embodiment, the anchor wires 84 are associated with a capstan or spool or spindle 134, with the capstan 134 controlling the tension on the anchor wires 84. The capstan 134 may also limit the total amount of line released to hold the deployed first and second elongated members 12 and 14 at the desired location in close proximity to the distal end 80 of the cannula 82. The tension in the anchor wires 84 may also be controlled by other means such as springs, resilient means, sliding mechanisms, rotating mechanisms, moving mechanisms, pulleys, stretchable lines and the like.

The free end 96 of the locking member 18 may also be adjustably secured to a rotary mechanism (similar to the pull wire 74 and the anchor wires 84) or to a non-rotational component of the delivery device 126 or may extend through the delivery device 126 without being secured thereto.

As described above, after the distraction device 10 has been deployed, the pull wire 74 may be severed and removed. In the illustrated embodiment, the delivery device 126 includes a shearing assembly 136 (FIG. 21) for severing or cutting the pull wire 74 (or any of the other wires, as desired). The shearing assembly 136 includes a stationary member 138 that is fixedly secured to the delivery device 126 and a movable member 140 that is rotatably secured to the stationary member 138 (e.g., by a cap 142). The pull wire 74 (or any other wire to be severed by the shearing assembly 136) extends through the stationary and movable members 138 and 140. When it is desirable to sever the pull wire 74 (or any of the other wires or filaments described herein, such as the anchor wires 84), the movable member 140 is rotated with respect to the stationary member 138 to cut or shear or otherwise sever the pull wire 74. Another portion of the pull wire 74 may be secured at another location of the delivery device 126, such that proximal movement of the delivery device 126 (e.g., removing the delivery device 126 from the work space) will cause the pull wire 74 to withdraw from the first and second elongated member 12 and 14.

A tool kit may include a number of related components and tools (illustrated in FIGS. 22-27) that may be used in connection with the delivery device 126. For example, FIG. 22 shows a pusher device or plunger 144 that may be used to push the augmenting elongated member 16 out of the deployment cannula 82 and into place between the first and second elongated members 12 and 14. The insertion knob 132 and slider 128 (if provided) may have central openings through which the pusher device 144 may extend to contact the proximal end 98 of the augmenting elongated member 16. In one embodiment, the distal end of the pusher device 144 is configured to engage and rotate the fastener 114 of the augmenting elongated member 16, as described above. In other embodiments, a separate device may be employed to advance the fastener 114 to the point that it severs and secures the free end 96 of the locking member 18.

FIG. 23 shows an extraction device 146 that may be used independently or in combination with the delivery device 126 to remove the distraction device 10 or an individual elongated member from the work space, if necessary.

FIGS. 24 and 25 show disc space sizing devices or paddles 148 and 150 that may be used prior to introduction of the delivery device 126 to the disc space. According to conventional usage, the disc space sizing devices 148 and 150 are inserted into the disc space to determine the minimum and proper heights of the disc space. When the minimum and proper heights have been determined, the appropriate delivery device may be selected from a kit that includes a plurality of delivery devices of varying heights.

FIGS. 26 and 27 show a funnel 152 and tamp 154 that may be used after the delivery device 126 has been removed from a work space to deliver a bone filler material 156 (FIG. 2) into the open interior or resident volume 108 of the distraction device 10, as will be described in greater detail herein. As used herein, “resident volume” refers generally to a structural characteristic of the support structure. The resident volume is a volume that is generally defined by the distraction device. The resident volume is preferably, but not necessarily, a volume completely enclosed by the distraction device, but can also be any volume generally defined by the distraction device. This term does not necessarily mean that the resident volume is an open or void volume or cavity and does not preclude a situation in which the resident volume is, at some point in time, filled with another material, such as bone graft, cement, therapeutic drugs or the like. It also does not preclude the resident volume from containing undisturbed human tissue that is located or remains within the resident volume during or after deployment of the distraction device. For example, if the distraction device is employed to separate adjoining soft tissue layers, such as subcutaneous fat and underlying muscle tissue, the resident volume of the distraction device support structure may be hollow or void of tissue after separation. On the other hand, if inserted into a spinal disc space, the resident volume may contain undisturbed disc tissue such as a portion of the nucleus pulposus or bone graft material placed before or after installation.

FIGS. 28-33 illustrate an exemplary method of inserting the distraction device 10 into a vertebral disc space, with FIG. 2 showing the fully installed distraction device 10. According to the illustrated method, an access port is made through the annulus of a vertebral disc using instruments and endoscopic or minimally invasive procedures generally known to those skilled in the art. The access port may be relatively small (e.g., no larger than the size of the deployment cannula 82), such that the procedure may be minimally invasive, with the resulting tissue distraction height being greater than the height of the access port. The location of the access port may vary without departing from the scope of the present disclosure, but it is preferred for the location of the access port be chosen so as to decrease the risk of nerve damage. In one embodiment (which is illustrated in FIG. 28), the access port is positioned so as to facilitate a transforaminal lumbar interbody fusion (“TLIF”) approach, but other approaches may also be practiced without departing from the scope of the present disclosure. For example, according to another approach, the access port may be positioned so as to facilitate deployment of the elongated members through Kambin's triangle, which is defined by the exiting nerve root (the hypotenuse of the triangle), the superior border of the inferior vertebra (the base of the triangle), and the traversing nerve root (the height of the triangle). While this approach results in an access port that is positioned at a different location than in the illustrated TLIF approach, it should be understood that the method of inserting the elongated members so as to define the implant in situ (described below in greater detail) may be substantially the same.

Optionally, all or a portion of the nucleus pulposus is removed and the endplates of the adjacent vertebrae are scraped to cause bleeding and promote the fusion of bone graft material to the vertebral endplates. Sizing paddles 148, 150 (FIGS. 24 and 25) or like apparatus, may be slipped through the access port to determine the minimum disc height and the desired final disc height. Based on the minimum and desired final disc height measurement from the sizing paddles 148, 150, the physician chooses the deployment cannula and distraction device sizes. The maximum outer dimension of the deployment cannula 82 used to deliver the distraction device 10 is preferably similar or slightly smaller in height than the minimum disc height measured. Accounting for the cannula wall thickness and any gap between the cannula 82 and the top-to-bottom height of the first and second elongated members 12 and 14, the first and second elongated members 12 and 14 together are selected so as to be slightly less in height, top to bottom, than the minimum disc height.

When the appropriate deployment cannula 82 and distraction device 10 have been selected, a distal end 80 of the deployment cannula 82 is advanced through the access port and into the disc space (FIG. 28). The deployment cannula 82 may be part of a delivery device 126 of the type illustrated in FIGS. 19 and 20 and described above or any other suitable delivery device. The first and second elongated members 12 and 14 are pre-loaded at a distal region of the deployment cannula 82 in a generally linear configuration for simultaneous insertion into the disc space. The augmenting elongated member 16 may be similarly pre-loaded in the deployment cannula 82 in a generally linear configuration, but positioned proximally of the first and second elongated members 12 and 14 for insertion after the first and second elongated members 12 and 14.

Because the first and second elongated members 12 and 14 together clear the minimum disc height, they can be pushed out of the deployment cannula 82 and into the disc space easily using the delivery device 126 or the like. For delivery, the physician begins to push in the first and second elongated members 12 and 14 simultaneously out of the cannula 82 little by little, for example by using a pusher or plunger or other suitable actuating means, such as a rotary actuator. Between pushes, the physician may check the curvature of the partially inserted first and second elongated members 12 and 14 (FIG. 29) using X-ray or other visualization techniques to observe the position of the elongated members via radiopaque portions thereof (such as radiopaque markers embedded within the elongated members). By tensioning the pull wire 74, as described above, the physician adjusts the curvature of the first and second elongated members 12 and 14 in real time to closely follow the inner wall of the disc annulus.

By the time the first and second elongated members 12 and 14 are entirely out of the cannula 82 and within the disc space, the distal or leading ends 28 and 24 of the first and second elongated members 12 and 14 may be adjacent to and/or in contact with the proximal ends 52 and 54 of the first and second elongated members 12 and 14. If not, additional tension may be applied to the pull wire 74 until the distal or leading end 28 and 24 of the first and second elongated members 12 and 14 are adjacent to and/or in contact with the proximal ends 52 and 54 of the first and second elongated member 12 and 14. As shown in FIG. 30, the fully inserted first and second elongated members 12 and 14 define a generally less linear or generally annular configuration prior to the augmenting elongated member 16 being inserted therebetween.

With the first and second elongated members 12 and 14 fully deployed from the cannula 82 and in the generally annular configuration of FIG. 30, they are held to the leading or distal end 80 of the cannula 82 by the tension in the pull wire 74 and/or the anchor wires 84. The physician then advances the augmenting elongated member 16 out of the cannula 82 (or, if the augmenting elongated member 16 is not pre-loaded in the cannula 82, the physician loads the augmenting elongated member 16 into the delivery system and then advances it out of the cannula 82). The augmenting elongated member 16 is received between the first and second elongated members 12 and 14 and follows the path or generally less linear shape defined by the first and second elongated members 12 and 14 until it has been at least partially (but most preferably fully) inserted therebetween. The locking features described above, if provided, may assist the augmenting elongated member 16 in following the path defined by the first and second elongated member 12 and 14, while also preventing the first and second elongated members 12 and 14 from disengaging with the augmenting elongated member 16. While inserting the augmenting elongated member 16, the physician should be careful to maintain the cannula 82 in place, as the location of the cannula 82 effects the placement of the first and second elongated members 12 and 14 and, hence, the resulting distraction device 10. The physician may check the alignment of all of the elongated members during insertion of the augmenting elongated member 16 using X-ray or other visualization techniques.

When first advanced out of the cannula 82, the augmenting elongated member 16 begins to wedge itself in between the first and second elongated members 12 and 14. Depending on the thickness (height) of the augmenting elongated member 16, some slack may need to be given at this point to the pull wire 74 and/or the anchor wires 84 to allow them to separate in a vertical direction (i.e., in a direction between the surfaces to be distracted or along the axis of the spine or the direction of distraction) to allow further advancement of the augmenting elongated member 16.

Once the physician confirms that the tip of the augmenting elongated member 16 is wedged securely and the raised ribs 48 and 50 and associated grooves 42 and 46 (if provided) of the three elongated members are engaged, the augmenting elongated member 16 is advanced slowly while checking for changes in the curvature of the distraction device 10. As before, the curvature can be adjusted in real time using the pull wire 74. In a preferred embodiment, the curvature may be adjusted automatically by developing tension in the pull wire 74 via a screw or rotational mechanism incorporated into or associated with the slider 128. The augmenting elongated member 16 is preferably pushed in all the way until its back face is flush with the back faces of the first and second elongated members 12 and 14 (FIG. 31), at which point the augmenting elongated member 16 may be fully locked in place with respect to the first and second elongated members 12 and 16.

The physician then makes a final check of the implant placement and desired distraction. If satisfied, the physician detaches the pull wire 74 and anchor wires 84 from the implant 10 (as described above) and may remove the cannula 82 and associated delivery device 126. Even with the pull wire 74 detached from the implant 10, the reaction force applied to the implant 10 by the tissues being distracted should be sufficient to maintain the implant 10 in the illustrated generally annular configuration.

As shown in FIG. 31, the augmenting elongated member 16 may have a linear extent that is less than the linear extents of the first and second elongated members 12 and 14 in the insertion or longitudinal direction (i.e., in a dimension extending between the proximal and distal ends of the elongated members). Thus, when the augmenting elongated member 16 has been fully inserted between the first and second elongated members 12 and 14 (such that their back faces are substantially flush), the augmenting elongated member 16 will define a generally less linear configuration that extends over a lesser arc than the generally complete circle defined by the first and second elongated members 12 and 14. In particular, the augmenting elongated member 16 defines a generally arcuate, non-annular configuration when fully inserted, such that a window 158 is defined between the proximal and distal ends 98 and 56 of the augmenting elongated member 16 (which define lateral sides of the window 158) and the distal ends 28 and 24 of the first and second elongated members 12 and 14 (which define lower and upper sides of the window 158, respectively).

The locking member 18, as described above, may separate from the lateral groove 106 in which it sits during (or after) insertion of the augmenting elongated member 16 to extend through the open interior or resident volume 108 defined by the implant 10. At this point, it may be advantageous for the locking member 18 to not be fully tensioned, otherwise it may obstruct the window 158, as shown in FIG. 16. As described above, the reaction forces applied to the fully expanded implant 10 by the opposing tissue surfaces should be sufficient to maintain the shape of the implant 10 even without shaping force being applied by the pull wire 74 or the locking member 18. However, it may be preferred for some amount of tension to be applied to the locking member 18 to remove it from the resident volume 108 and position it in the window 158, but with sufficient slackness that the locking member 18 does not extend across the middle of the window 158. Instead, it may be preferred for the locking member 18 to hang slack within the window 158, as shown in FIGS. 15 and 31, to allow a funnel 152 (FIG. 32) to extend through the window 158 and access the resident volume 108 without contacting the locking member 18.

As shown in FIG. 32, if bone graft material or bone filler material 156 is needed, it can be injected or otherwise introduced into the open interior or resident volume 108 defined by the implant 10 via the window 158 defined in the side wall of the implant 10. In the illustrated embodiment, the distal end of a funnel 152 is inserted through the window 158 and then bone graft material or bone filler material 156 is advanced through the funnel 152 and into the resident volume 108 using a tamp 154 of the type shown in FIG. 27 or the like. FIG. 32 shows the resident volume 108 being substantially entirely filled with bone graft material or bone filler material 156, but it is also within the scope of the present disclosure for the resident volume 108 to be only partially filled with bone graft material or bone filler material 108. An advantage of implants according to the present disclosure is that, unlike most other expandable cages, bone graft material or bone filler material it meant to be place through the window defined in the side wall of the implant and make full contact on the two tissue surfaces to be distracted. Some expandable cage-type implants include bone graft material within the cage as it is introduced into the disc space, and then expand the cage, which tends to leave voids between the bone graft material and the tissue surfaces to be distracted. Voids in bone graft are undesirable, as they may inhibit fusion or the rate of fusion between vertebral endplates.

When the desired amount of bone graft material or bone filler material 156 has been introduced into the resident volume 108, the physician withdraws the funnel 152 and then applies a proximally directed force to the free end 96 of the locking member 18 (FIG. 33). Tension is applied to the locking member 18 until it is taut or tightly drawn across the middle of the window 158 (FIG. 16). Then, the fastener 114 of the augmenting elongated member 16 is advanced so as to sever the free end 96 of the locking member 18, while securing the locking member 18 to the augmenting elongated member 16 at a second location, as described in greater detail above. The fastener 114 may be advanced by a driver device 160 (FIG. 33) that pushes or rotates or otherwise actuates the fastener 114 so as to move it distally with respect to the augmenting elongated member 16 into contact with the locking member 18.

The free end 96 of the locking member 18 being secured and severed, the severed portion may be removed from the disc space, along with the driver device 160, leaving only the fully deployed implant 10 in the disc space, as shown in FIG. 2. Thereafter, the access port may be closed, along with any other access points opened to reach the disc space.

It should be understood that the above-described elongated members, distraction device, deployment tools, and methods are merely exemplary. For example, FIGS. 34 and 35 illustrate an alternative embodiment of an elongated member or distraction device 162 employing a different locking mechanism or member 164 (FIG. 35). In the illustrated embodiment, the elongated member or distraction device 162 is moved from a generally linear configuration to a generally less linear configuration (e.g., as described above using a pull wire or the like) with the elongated member or distraction device 162 assuming an arcuate, but not closed loop or annular, shape. The gap 166 between the proximal and distal ends 168 and 170 of the elongated member or distraction device 162 may be used to introduce bone graft material or the like into the resident volume 172 defined by the elongated member or distraction device 162. When the surgeon desires to close the gap 166, the proximal and distal ends 168 and 170 are drawn together (e.g., using a closure tool 174 that engages the proximal and distal ends 168 and 170 to bring them toward each other) and a fastener or fixture 164 is secured to the ends 168 and 170 to prevent them from separating. In one embodiment, the fastener or fixture 164 comprises a staple with two prongs 176 and 178 that are received within cavities 180 and 182 of the proximal and distal ends 168 and 170 to close the gap 166 and maintain the elongated member or distraction device 162 in a generally annular configuration.

In other embodiments, a separate fastener or fixture is not required to maintain the elongated member or distraction device in a generally annular configuration. For example, FIG. 36 shows a distraction device 184 in which one of the constituent elongated members (shown as the augmenting elongated member 186) includes an embedded wire or tube or elongated element 188 made of a material having shape memory properties, such as Nitinol or a shape memory polymer. The embedded element 188 preferably has a natural or pre-set shape, for example, the illustrated arcuate or annular configuration. When the augmenting elongated member 186 is present in a deployment cannula, it is constrained to a generally linear configuration, allowing for an easy and minimally invasive deployment of the elongated members into the work space. Because of the shape memory properties of the embedded element 188, the augmenting elongated member 186 will return to its natural curved or annular shape once the constraint is removed (i.e., once the distal end of the augmenting elongated member 186 exits the distal end portion of the cannula and enters the work space). Rather than being embedded within the augmenting elongated member 186, the shape memory material may instead be secured to an outer surface (e.g., a lateral side) of the augmenting elongated member 186. In other embodiments, one or both of the upper and lower elongated members 190 and 191 includes shape memory properties in addition to (or instead of) the augmenting elongated member 186 having shape memory properties. By providing one or more of the elongated members with shape memory properties, the need to use a locking member or fastener or fixture to secure the resulting distraction device in its generally less linear, deployed configuration is avoided.

FIGS. 37 and 38 illustrate another embodiment of an elongated member or distraction device 192 that may maintain a generally less linear, deployed configuration without the need for a separate fixture or fastener or locking member. The illustrated elongated member or distraction device 192 includes an integrally formed locking projection or extension 194 at its distal end 196 and a similarly shaped cavity or pocket 198 along a lateral side 200 at or adjacent to its proximal end 202. The cavity 198 is preferably associated with the lateral side 200 of the elongated member or distraction device 192 toward which the elongated member or distraction device 192 curves when deployed in a work space. In the illustrated embodiment, the elongated member or distraction device 192 may be moved from a generally linear configuration to a generally less linear configuration (e.g., as described above using a pull wire or the like) with the elongated member or distraction device 192 assuming an arcuate, but not closed loop or annular, shape with a gap between the proximal and distal ends 202 and 196. The gap between the proximal and distal ends 202 and 196 of the elongated member or distraction device 192 may be used to introduce bone graft material or the like into the resident volume 204 defined by the elongated member or distraction device 192. When the surgeon desires to close the gap, the locking projection 194 is pressed into and retained by the cavity 198, as shown in FIG. 38. In the illustrated embodiment, the locking projection 194 is generally conical, which may promote retention of the projection 194 within the cavity 198, but other locking projection configurations (e.g., an enlarged spherical shape) may also be employed without departing from the scope of the present disclosure.

It will be understood that the embodiments described above are illustrative of some of the applications of the principles of the present subject matter. Numerous modifications may be made by those skilled in the art without departing from the spirit and scope of the claimed subject matter, including those combinations of features that are individually disclosed or claimed herein. For these reasons, the scope hereof is not limited to the above description but is as set forth in the following claims, and it is understood that claims may be directed to the features hereof, including as combinations of features that are individually disclosed or claimed herein.

Claims

1. A tissue distraction device comprising:

first and second elongated members, each elongated member defining a closed loop in a separate plane in a deployed configuration, wherein the first elongated member comprises a first elongated member proximal end and a first elongated member distal end; and
an augmenting elongated member fully comprising an augmenting elongated member proximal end and an augmenting elongated member distal end, wherein the augmenting elongated member is configured to be moved toward the first elongated member distal end to be fully received between the first and second elongated members in the deployed configuration and having a length that is less than the length of each of the first and second elongated members wherein the augmenting elongated ember distal end stops short of the first elongated member distal end in the deployed configuration.

2. The tissue distraction device of claim 1, wherein the augmenting, first, and second elongated members cooperate to define a window into an interior of the tissue distraction device.

3. The tissue distraction device of claim 2, wherein the window is configured to allow for the introduction of a bone filler material into the interior of the tissue distraction device through the window.

4. The tissue distraction device of claim 2, further comprising a locking member secured to the augmenting elongated member at a plurality of locations to lock the augmenting elongated member in a generally arcuate configuration, wherein a portion of the locking member extends across the window.

5. The tissue distraction device of claim 4, further comprising a fastener, wherein

the locking member extends between a fixed end and a free end,
the fixed end of the locking member is secured at or adjacent to a proximal end of the augmenting elongated member, and
the fastener secures the free end of the locking member to the augmenting elongated member at or adjacent to the proximal end of the augmenting elongated member.

6. The tissue distraction device of claim 1, wherein the first, second, and augmenting elongated members combine to define a structure having a non-uniform thickness configured to adjust the lordotic angle of the a spine.

7. The tissue distraction device of claim 1, wherein

each of the first and second elongated members extends between proximal and distal ends and includes a lateral side, and
one of the ends end of the first elongated member contacts the approaches a lateral side of the first elongated member adjacent to the other end of the first elongated member, and
one of the ends end of the second elongated member contacts the approaches a lateral side of the second elongated member adjacent to the other end of the second elongated member.

8. The tissue distraction device of claim 1, wherein each elongated member is generally rectangular in cross-sectional shape and defined by elongated upper and lower surfaces, proximal and distal ends, and elongated lateral side surfaces.

9. The tissue distraction device of claim 8 1, wherein each of the elongated members includes

a longitudinally extending wall,
a plurality of similarly shaped first teeth extending laterally from the longitudinally extending wall in one direction, and
a plurality of similarly shaped second teeth extending laterally from the longitudinally extending wall in an opposite direction and differently configured from said first teeth.

10. A tissue distraction device comprising:

first and second elongated members insertable between tissue layers and adapted to define a structure in situ having a dimensional aspect dimension in a direction extending between the tissue layers; and
an augmenting elongated member insertable between and in contact with said first and second elongated members to spread the first and second elongated members apart to increase the dimension of at least a portion of the structure in situ, wherein
each elongated member is generally rectangular in cross-sectional shape and defined by elongated upper and lower surfaces, proximal and distal ends, and elongated lateral side surfaces,
each elongated member is the first and second elongated members are sufficiently flexible to change between a generally linear first configuration and a second configuration that is less linear than the first configuration, wherein the first elongated member comprises a first elongated member proximal end and a first elongated member distal end, and wherein
the augmenting elongated member has a length that is less than the length of each of the first and second elongated members comprises an augmenting elongated member proximal end and an augmenting elongated member distal end, wherein the augmenting elongated member is configured to be moved toward the first elongated member distal end to be received between the first and second elongated members in the deployed configuration and the augmenting elongated member distal end stops short of the first elongated member distal end in the deployed configuration.

11. The tissue distraction device of claim 10, wherein each of the elongated members includes

a longitudinally extending wall,
a plurality of similarly shaped first teeth extending laterally from the longitudinally extending wall in one direction, and
a plurality of similarly shaped second teeth extending laterally from the longitudinally extending wall in an opposite direction and differently configured from said first teeth.

12. The tissue distraction device of claim 10, wherein

the proximal end of each of the first and second elongated members is ramped, and
the distal end of the augmenting elongated member augmenting elongated member distal end is tapered to engage and separate the first and second elongated members when the augmenting elongated member is inserted therebetween.

13. The tissue distraction device of claim 10, wherein the augmenting elongated member is configured to cooperate with said first and second elongated members to define a window into an interior of the tissue distraction device when the augmenting elongated member is inserted between and in contact with said first and second elongated members and the elongated members are in the second configuration.

14. The tissue distraction device of claim 13, further comprising a locking member configured to be secured to the augmenting elongated member at a plurality of locations to lock the augmenting elongated member in the second configuration in which a portion of the locking member extends across the window.

15. The tissue distraction device of claim 14, further comprising a fastener, wherein

the locking member extends between a fixed end and a free end,
the fixed end of the locking member is secured at or adjacent to a proximal end of the augmenting elongated member, and
the fastener is configured to secure the free end of the locking member to the augmenting elongated member at or adjacent to the proximal end of the augmenting elongated member when the augmenting elongated member is in the second configuration.

16. The tissue distraction device of claim 10, wherein the first, second, and augmenting elongated members are configured to combine to define a structure having a non-uniform thickness configured to adjust the lordotic angle of the a spine.

17. The tissue distraction device of claim 10, wherein

one of the ends end of the first elongated member is configured to contact one of the lateral sides approach a lateral side of the first elongated member adjacent to the other end of the first elongated member when the first elongated member is in the second configuration, and
one of the ends end of the second elongated member is configured to contact one of the lateral sides approach a lateral side of the second elongated member adjacent to the other end of the second elongated member when the second elongated member is in the second configuration.

18. The tissue distraction device of claim 10, wherein each of the first and second elongated members is configured to define a closed loop an annular shape in the second configuration.

19. The tissue distraction device of claim 18, wherein the augmenting elongated member is configured to define a generally arcuate configuration in the second configuration.

20. The tissue distraction device of claim 10, wherein

each of the first and second elongated members is configured to define a closed loop an annular shape in the second configuration,
the augmenting elongated member is configured to cooperate with said first and second elongated members to define a window into an interior of the tissue distraction device in the second configuration, and
the window is configured to allow for the introduction of a bone filler material into the interior of the tissue distraction device in the second configuration through the window.

21. A tissue distraction device comprising:

first and second elongated members insertable between tissue layers and adapted to define a structure in situ having a dimension in a direction extending between the tissue layers, wherein the first elongated member comprises a first elongated member proximal end and a first elongated member distal end; and
an augmenting elongated member comprising an augmenting elongated member proximal end and an augmenting elongated member distal end, wherein the augmenting elongated member is insertable between and in contact with said first and second elongated members to spread the first and second elongated members apart to increase the dimension of at least a portion of the structure in situ in a deployed configuration, wherein the augmenting elongated member is configured to be moved toward the first elongated member distal end to be received between the first and second elongated members in the deployed configuration and the augmenting elongated member distal end stops short of the first elongated member distal end in the deployed configuration.

22. The tissue distraction device of claim 21, wherein the augmenting, first, and second elongated members cooperate to define a window.

23. The tissue distraction device of claim 22, wherein the window is configured to allow for the introduction of a bone filler material through the window.

24. The tissue distraction device of claim 21, wherein the first, second, and augmenting elongated members combine to define a structure having a non-uniform thickness configured to adjust the lordotic angle of a spine.

25. The tissue distraction device of claim 21, wherein

one end of the first elongated member approaches a lateral side of the first elongated member adjacent to the other end of the first elongated member, and
one end of the second elongated member approaches a lateral side of the second elongated member adjacent to the other end of the second elongated member.

26. The tissue distraction device of claim 21, wherein each elongated member is generally rectangular in cross-sectional shape.

27. The tissue distraction device of claim 21, wherein each of the elongated members includes

a longitudinally extending wall,
a plurality of first teeth extending laterally from the longitudinally extending wall in one direction, and
a plurality of second teeth extending laterally from the longitudinally extending wall in an opposite direction.

28. The tissue distraction device of claim 1, wherein the augmenting, first, and second elongated members cooperate to define a window which is adjacent to the augmenting elongated member distal end.

29. The tissue distraction device of claim 10, wherein the augmenting, first, and second elongated members cooperate to define a window which is adjacent to the augmenting elongated member distal end.

30. The tissue distraction device of claim 21, wherein the augmenting, first, and second elongated members cooperate to define a window which is adjacent to the augmenting elongated member distal end.

31. The tissue distraction device of claim 1, wherein the augmenting, first, and second elongated members cooperate to define a window, wherein the augmenting elongated member distal end defines a lateral side of the window.

32. The tissue distraction device of claim 10, wherein the augmenting, first, and second elongated members cooperate to define a window, wherein the augmenting elongated member distal end defines a lateral side of the window.

33. The tissue distraction device of claim 21, wherein the augmenting, first, and second elongated members cooperate to define a window, wherein the augmenting elongated member distal end defines a lateral side of the window.

34. The tissue distraction device of claim 1, wherein the augmenting, first, and second elongated members cooperate to define a window, wherein the first and second elongated members define lower and upper sides of the window.

35. The tissue distraction device of claim 10, wherein the augmenting, first, and second elongated members cooperate to define a window, wherein the first and second elongated members define lower and upper sides of the window.

36. The tissue distraction device of claim 21, wherein the augmenting, first, and second elongated members cooperate to define a window, wherein the first and second elongated members define lower and upper sides of the window.

37. The tissue distraction device of claim 1, wherein a window is defined between the augmenting elongated member proximal end and the augmenting elongated member distal end, which define lateral sides of the window, and the first elongated member distal end and the second elongated member distal end, which define lower and upper sides of the window.

38. The tissue distraction device of claim 10, wherein a window is defined between the augmenting elongated member proximal end and the augmenting elongated member distal end, which define lateral sides of the window, and the first elongated member distal end and the second elongated member distal end, which define lower and upper sides of the window.

39. The tissue distraction device of claim 21, wherein a window is defined between the augmenting elongated member proximal end and the augmenting elongated member distal end, which define lateral sides of the window, and the first elongated member distal end and the second elongated member distal end, which define lower and upper sides of the window.

Referenced Cited
U.S. Patent Documents
2002021 May 1935 Rouse
3807390 April 1974 Ostrowski et al.
4846175 July 11, 1989 Frimberger
4862891 September 5, 1989 Smith
4863476 September 5, 1989 Shepperd
4898161 February 6, 1990 Grundei
5059193 October 22, 1991 Kuslich
5129889 July 14, 1992 Hahn et al.
5192327 March 9, 1993 Brantigan
5201742 April 13, 1993 Hasson
5219358 June 15, 1993 Bendel et al.
5267994 December 7, 1993 Gentelia et al.
5306310 April 26, 1994 Siebels
5342394 August 30, 1994 Matsuno et al.
5345945 September 13, 1994 Hodgson et al.
5366490 November 22, 1994 Edwards et al.
5374267 December 20, 1994 Siegal
5383884 January 24, 1995 Summers
5397304 March 14, 1995 Truckai
5397364 March 14, 1995 Kozak et al.
5423806 June 13, 1995 Dale et al.
5433739 July 18, 1995 Sluijter et al.
5445639 August 29, 1995 Kuslich et al.
5470043 November 28, 1995 Marts et al.
5487757 January 30, 1996 Truckai et al.
5500012 March 19, 1996 Brucker et al.
5540696 July 30, 1996 Booth, Jr. et al.
5549679 August 27, 1996 Kuslich
5554163 September 10, 1996 Shturman
5571147 November 5, 1996 Sluijter et al.
5571189 November 5, 1996 Kuslich
5599346 February 4, 1997 Edwards et al.
5697909 December 16, 1997 Eggers et al.
5716416 February 10, 1998 Lin
5718707 February 17, 1998 Mikhail
5755661 May 26, 1998 Schwartzman
5755732 May 26, 1998 Green et al.
5755797 May 26, 1998 Baumgartner
5782832 July 21, 1998 Larsen et al.
5788713 August 4, 1998 Dubach et al.
5851214 December 22, 1998 Larsen et al.
5865809 February 2, 1999 Moenning et al.
5871501 February 16, 1999 Leschinsky et al.
5885217 March 23, 1999 Gisselberg et al.
5916166 June 29, 1999 Reiss et al.
5919235 July 6, 1999 Husson et al.
5980471 November 9, 1999 Jafari
5980504 November 9, 1999 Sharkey et al.
6007570 December 28, 1999 Sharkey et al.
6019765 February 1, 2000 Thornhill et al.
6039761 March 21, 2000 Li et al.
6059829 May 9, 2000 Schläpfer et al.
6099514 August 8, 2000 Sharkey et al.
6126660 October 3, 2000 Dietz
6126682 October 3, 2000 Sharkey et al.
6183517 February 6, 2001 Suddaby
6224630 May 1, 2001 Bao et al.
6228022 May 8, 2001 Friesem et al.
6231609 May 15, 2001 Mehdizadeh
6245072 June 12, 2001 Zdeblick
6245107 June 12, 2001 Ferree
6277112 August 21, 2001 Underwood et al.
6332895 December 25, 2001 Suddaby
6375635 April 23, 2002 Moutafis et al.
6375682 April 23, 2002 Fleischmann et al.
6387130 May 14, 2002 Stone et al.
6409766 June 25, 2002 Brett
6419704 July 16, 2002 Ferree
6436142 August 20, 2002 Paes et al.
6454806 September 24, 2002 Cohen et al.
6468270 October 22, 2002 Hovda et al.
6488710 December 3, 2002 Besselink
6491690 December 10, 2002 Goble et al.
6500205 December 31, 2002 Michelson
6530926 March 11, 2003 Davison
6551319 April 22, 2003 Lieberman
6554833 April 29, 2003 Levy et al.
6558383 May 6, 2003 Cunningham et al.
6558386 May 6, 2003 Cragg
6558390 May 6, 2003 Cragg
6562033 May 13, 2003 Shah et al.
6582431 June 24, 2003 Ray
6592625 July 15, 2003 Cauthen
6595998 July 22, 2003 Johnson et al.
6602248 August 5, 2003 Sharps et al.
6607505 August 19, 2003 Thompson et al.
6607530 August 19, 2003 Carl et al.
6620196 September 16, 2003 Trieu
6656178 December 2, 2003 Veldhuizen et al.
6670505 December 30, 2003 Collins et al.
6676665 January 13, 2004 Foley et al.
6714822 March 30, 2004 King et al.
6726684 April 27, 2004 Woloszko et al.
6733496 May 11, 2004 Sharkey et al.
6749605 June 15, 2004 Ashley et al.
6764491 July 20, 2004 Frey et al.
6767347 July 27, 2004 Sharkey et al.
6773432 August 10, 2004 Clayman et al.
6821276 November 23, 2004 Lambrecht et al.
6830570 December 14, 2004 Frey et al.
6878155 April 12, 2005 Sharkey et al.
6923811 August 2, 2005 Carl et al.
6939351 September 6, 2005 Eckman
6953458 October 11, 2005 Loeb
6964667 November 15, 2005 Shaolian et al.
6976949 December 20, 2005 Winkler et al.
7004970 February 28, 2006 Cauthen, III et al.
7008432 March 7, 2006 Schlapfer et al.
7025765 April 11, 2006 Balbierz et al.
7052516 May 30, 2006 Cauthen, III et al.
7056321 June 6, 2006 Pagliuca et al.
7069087 June 27, 2006 Sharkey et al.
7087055 August 8, 2006 Lim et al.
7087058 August 8, 2006 Cragg
7114501 October 3, 2006 Johnson et al.
7124761 October 24, 2006 Lambrecht et al.
7144397 December 5, 2006 Lambrecht et al.
7179225 February 20, 2007 Shluzas et al.
7204853 April 17, 2007 Gordon et al.
7211055 May 1, 2007 Diederich et al.
7241297 July 10, 2007 Shaolian et al.
7252686 August 7, 2007 Carrison et al.
7267687 September 11, 2007 McGuckin, Jr.
7282020 October 16, 2007 Kaplan
7309336 December 18, 2007 Ashley et al.
7318823 January 15, 2008 Sharps et al.
7318826 January 15, 2008 Teitelbaum et al.
7322962 January 29, 2008 Forrest
7331956 February 19, 2008 Hovda et al.
7331963 February 19, 2008 Bryan et al.
RE40156 March 18, 2008 Sharps et al.
7618458 November 17, 2009 Biedermann et al.
7682378 March 23, 2010 Truckai et al.
7753912 July 13, 2010 Raymond et al.
7758647 July 20, 2010 Arnin et al.
7771432 August 10, 2010 Schwab et al.
7776051 August 17, 2010 Colleran et al.
7824445 November 2, 2010 Biro et al.
7887568 February 15, 2011 Ahlgren
7901460 March 8, 2011 Sherman
7922767 April 12, 2011 Sack et al.
7947078 May 24, 2011 Siegal
7963915 June 21, 2011 Bleich
8021429 September 20, 2011 Viker
8025697 September 27, 2011 McClellan, III et al.
8083796 December 27, 2011 Raiszadeh et al.
8123750 February 28, 2012 Norton et al.
8128662 March 6, 2012 Altarac et al.
8137401 March 20, 2012 Stad et al.
8142507 March 27, 2012 McGuckin, Jr.
8246622 August 21, 2012 Siegal et al.
8252001 August 28, 2012 Quimo et al.
8252054 August 28, 2012 Greenhalgh et al.
8377070 February 19, 2013 Gauthier
8394102 March 12, 2013 Garabedian et al.
8454617 June 4, 2013 Schaller et al.
8454622 June 4, 2013 Blain et al.
8470043 June 25, 2013 Schaller et al.
8579980 November 12, 2013 DeLurio et al.
8591583 November 26, 2013 Schaller et al.
8628577 January 14, 2014 Jimenez
8632591 January 21, 2014 Vila et al.
8663332 March 4, 2014 To et al.
8685031 April 1, 2014 Kleiner et al.
8764806 July 1, 2014 Abdou
8906028 December 9, 2014 Kleiner
8968408 March 3, 2015 Schaller et al.
8974464 March 10, 2015 Johnson et al.
8979860 March 17, 2015 Voellmicke et al.
8986385 March 24, 2015 Hall
9034041 May 19, 2015 Wolters et al.
9039771 May 26, 2015 Glerum et al.
9161773 October 20, 2015 Schaller et al.
9308022 April 12, 2016 Chitre et al.
9351851 May 31, 2016 Huffmaster et al.
9480574 November 1, 2016 Lee et al.
9566170 February 14, 2017 Schell et al.
9642712 May 9, 2017 Schaller et al.
9827031 November 28, 2017 Emery et al.
9955961 May 1, 2018 Huffmaster et al.
10022243 July 17, 2018 Emery et al.
10231843 March 19, 2019 Lee et al.
10258228 April 16, 2019 Genovese et al.
10285821 May 14, 2019 Schaller et al.
10314605 June 11, 2019 Huffmaster et al.
10426629 October 1, 2019 Schaller et al.
10575963 March 3, 2020 Schaller et al.
10709577 July 14, 2020 Lorang et al.
10758286 September 1, 2020 Ammerman et al.
11224453 January 18, 2022 Huffmaster et al.
11298043 April 12, 2022 Bankiewicz et al.
11471145 October 18, 2022 Pacheco-Serrant et al.
11564811 January 31, 2023 Lorang et al.
11583327 February 21, 2023 McHale et al.
20010023348 September 20, 2001 Ashley et al.
20010029377 October 11, 2001 Aebi et al.
20010031981 October 18, 2001 Evans et al.
20020019637 February 14, 2002 Frey et al.
20020026197 February 28, 2002 Foley et al.
20020128716 September 12, 2002 Cohen et al.
20020147444 October 10, 2002 Shah et al.
20020156530 October 24, 2002 Lambrecht et al.
20020173813 November 21, 2002 Peterson et al.
20030009223 January 9, 2003 Fehling et al.
20030014047 January 16, 2003 Woloszko et al.
20030040796 February 27, 2003 Ferree
20030065358 April 3, 2003 Frecker et al.
20030083747 May 1, 2003 Winterbottom et al.
20030158545 August 21, 2003 Hovda et al.
20030158553 August 21, 2003 Michelson
20030187453 October 2, 2003 Schlapfer et al.
20030204189 October 30, 2003 Cragg
20030220650 November 27, 2003 Major et al.
20040002762 January 1, 2004 Hawkins
20040010315 January 15, 2004 Song
20040015218 January 22, 2004 Finch et al.
20040024463 February 5, 2004 Thomas, Jr. et al.
20040049180 March 11, 2004 Sharps et al.
20040059333 March 25, 2004 Carl et al.
20040064144 April 1, 2004 Johnson et al.
20040073216 April 15, 2004 Lieberman
20040087994 May 6, 2004 Suddaby
20040092988 May 13, 2004 Shaolian et al.
20040102774 May 27, 2004 Trieu
20040106940 June 3, 2004 Shaolian et al.
20040116922 June 17, 2004 Hovda et al.
20040127893 July 1, 2004 Hovda
20040133280 July 8, 2004 Trieu
20040148028 July 29, 2004 Ferree et al.
20040153064 August 5, 2004 Foley et al.
20040167625 August 26, 2004 Beyar et al.
20040193158 September 30, 2004 Lim et al.
20040230198 November 18, 2004 Manzi et al.
20040230309 November 18, 2004 DiMauro et al.
20040249464 December 9, 2004 Bindseil et al.
20040260305 December 23, 2004 Gorensek et al.
20050021030 January 27, 2005 Pagliuca et al.
20050021041 January 27, 2005 Michelson
20050033292 February 10, 2005 Teitelbaum et al.
20050038517 February 17, 2005 Carrison et al.
20050049623 March 3, 2005 Moore et al.
20050065610 March 24, 2005 Pisharodi
20050070911 March 31, 2005 Carrison et al.
20050080425 April 14, 2005 Bhatnagar et al.
20050090833 April 28, 2005 DiPoto
20050090899 April 28, 2005 DiPoto
20050107878 May 19, 2005 Conchy
20050113832 May 26, 2005 Molz, IV et al.
20050119750 June 2, 2005 Studer
20050131540 June 16, 2005 Trieu
20050131541 June 16, 2005 Trieu
20050137601 June 23, 2005 Assell et al.
20050137605 June 23, 2005 Assell et al.
20050149049 July 7, 2005 Assell et al.
20050165420 July 28, 2005 Cha
20050182414 August 18, 2005 Manzi et al.
20050182416 August 18, 2005 Lim et al.
20050187537 August 25, 2005 Loeb et al.
20050203527 September 15, 2005 Carrison et al.
20050222683 October 6, 2005 Berry
20050228391 October 13, 2005 Levy et al.
20050234493 October 20, 2005 Carr et al.
20050240171 October 27, 2005 Forrest
20050251134 November 10, 2005 Woloszko et al.
20050251177 November 10, 2005 Saadat et al.
20050256525 November 17, 2005 Culbert et al.
20050261683 November 24, 2005 Veldhuizen et al.
20050261684 November 24, 2005 Shaolian et al.
20050261692 November 24, 2005 Carrison et al.
20050273173 December 8, 2005 Gordon et al.
20050278027 December 15, 2005 Hyde, Jr.
20050278036 December 15, 2005 Leonard et al.
20060015131 January 19, 2006 Kierce et al.
20060025797 February 2, 2006 Lock et al.
20060030933 February 9, 2006 DeLegge et al.
20060036241 February 16, 2006 Siegal
20060041258 February 23, 2006 Galea
20060041295 February 23, 2006 Osypka
20060047178 March 2, 2006 Winkler et al.
20060052793 March 9, 2006 Heinz
20060058826 March 16, 2006 Evans et al.
20060058876 March 16, 2006 McKinley
20060074425 April 6, 2006 Sutterlin et al.
20060085070 April 20, 2006 Kim
20060089646 April 27, 2006 Bonutti
20060116689 June 1, 2006 Albans
20060129244 June 15, 2006 Ensign et al.
20060136064 June 22, 2006 Sherman
20060149268 July 6, 2006 Truckai et al.
20060161162 July 20, 2006 Lambrecht et al.
20060178666 August 10, 2006 Cosman et al.
20060189999 August 24, 2006 Zwirkoski
20060195091 August 31, 2006 McGraw et al.
20060195094 August 31, 2006 McGraw et al.
20060206116 September 14, 2006 Yeung
20060217811 September 28, 2006 Lambrecht et al.
20060224154 October 5, 2006 Shadduck et al.
20060224241 October 5, 2006 Butler et al.
20060229625 October 12, 2006 Truckai et al.
20060235418 October 19, 2006 Gil et al.
20060241577 October 26, 2006 Balbierz et al.
20060247600 November 2, 2006 Yeung et al.
20060247784 November 2, 2006 Kim
20060265076 November 23, 2006 Carter et al.
20060265077 November 23, 2006 Zwirkoski
20060287726 December 21, 2006 Segal et al.
20060287727 December 21, 2006 Segal
20060287729 December 21, 2006 Segal et al.
20060287730 December 21, 2006 Segal et al.
20070010848 January 11, 2007 Leung et al.
20070016273 January 18, 2007 Scarborough et al.
20070027545 February 1, 2007 Carls et al.
20070032791 February 8, 2007 Greenhalgh
20070050030 March 1, 2007 Kim
20070050032 March 1, 2007 Gittings et al.
20070055259 March 8, 2007 Norton et al.
20070055262 March 8, 2007 Tomita et al.
20070055275 March 8, 2007 Schaller
20070060935 March 15, 2007 Schwardt et al.
20070067035 March 22, 2007 Falahee
20070093822 April 26, 2007 Dutoit et al.
20070093899 April 26, 2007 Dutoit et al.
20070118219 May 24, 2007 Hyde, Jr.
20070123888 May 31, 2007 Bleich et al.
20070123903 May 31, 2007 Raymond et al.
20070123986 May 31, 2007 Schaller et al.
20070149978 June 28, 2007 Shezifi et al.
20070149990 June 28, 2007 Palmer et al.
20070162032 July 12, 2007 Johnson et al.
20070162062 July 12, 2007 Norton et al.
20070162127 July 12, 2007 Peterman et al.
20070162135 July 12, 2007 Segal et al.
20070168041 July 19, 2007 Kadiyala
20070168043 July 19, 2007 Ferree
20070173939 July 26, 2007 Kim et al.
20070175959 August 2, 2007 Shelton, IV et al.
20070191837 August 16, 2007 Trieu
20070198021 August 23, 2007 Wales
20070198025 August 23, 2007 Trieu et al.
20070208426 September 6, 2007 Trieu
20070213704 September 13, 2007 Truckai et al.
20070213733 September 13, 2007 Bleich et al.
20070213734 September 13, 2007 Bleich et al.
20070213735 September 13, 2007 Saadat et al.
20070225703 September 27, 2007 Schmitz et al.
20070233143 October 4, 2007 Josse et al.
20070255286 November 1, 2007 Trieu
20070255406 November 1, 2007 Trieu
20070255703 November 1, 2007 Maruyama et al.
20070260252 November 8, 2007 Schmitz et al.
20070260270 November 8, 2007 Assell et al.
20070260315 November 8, 2007 Foley et al.
20070265652 November 15, 2007 Assell et al.
20070265691 November 15, 2007 Swanson
20070276406 November 29, 2007 Mahoney et al.
20070299521 December 27, 2007 Glenn et al.
20080009826 January 10, 2008 Miller et al.
20080009828 January 10, 2008 Miller et al.
20080009847 January 10, 2008 Ricart et al.
20080009875 January 10, 2008 Sankaran et al.
20080009876 January 10, 2008 Sankaran et al.
20080009877 January 10, 2008 Sankaran et al.
20080015639 January 17, 2008 Bjork et al.
20080021435 January 24, 2008 Miller et al.
20080027407 January 31, 2008 Miller et al.
20080033465 February 7, 2008 Schmitz et al.
20080058707 March 6, 2008 Ashley et al.
20080065080 March 13, 2008 Assell et al.
20080065092 March 13, 2008 Assell et al.
20080065093 March 13, 2008 Assell et al.
20080065094 March 13, 2008 Assell et al.
20080071356 March 20, 2008 Greenhalgh et al.
20080086157 April 10, 2008 Stad et al.
20080114367 May 15, 2008 Meyer
20080147113 June 19, 2008 Nobis et al.
20080161809 July 3, 2008 Schmitz et al.
20080177259 July 24, 2008 Wu
20080183204 July 31, 2008 Greenhalgh et al.
20080221687 September 11, 2008 Viker
20080228135 September 18, 2008 Snoderly
20080234687 September 25, 2008 Schaller et al.
20080249628 October 9, 2008 Altarac et al.
20080287995 November 20, 2008 Gauthier
20080294171 November 27, 2008 Boehm, Jr. et al.
20080300636 December 4, 2008 Carli et al.
20090012612 January 8, 2009 White et al.
20090024217 January 22, 2009 Levy et al.
20090105711 April 23, 2009 Mitchell et al.
20090143716 June 4, 2009 Lowry et al.
20090157187 June 18, 2009 Richelsoph
20090171390 July 2, 2009 Sankaran
20090198241 August 6, 2009 Phan
20090198245 August 6, 2009 Phan
20090234454 September 17, 2009 Siegal
20100030216 February 4, 2010 Arcenio
20100114179 May 6, 2010 Moore et al.
20100131005 May 27, 2010 Conlon
20100179578 July 15, 2010 Tannoury et al.
20100185291 July 22, 2010 Jimenez et al.
20100198263 August 5, 2010 Siegal et al.
20100228091 September 9, 2010 Widenhouse et al.
20100249798 September 30, 2010 Sournac et al.
20100262147 October 14, 2010 Siegal et al.
20100262242 October 14, 2010 Chavatte et al.
20100268234 October 21, 2010 Aho et al.
20100286782 November 11, 2010 Schaller et al.
20100298864 November 25, 2010 Castro
20110015638 January 20, 2011 Pischl et al.
20110015747 January 20, 2011 McManus et al.
20110112455 May 12, 2011 Rocklin
20110125266 May 26, 2011 Rodgers et al.
20110144440 June 16, 2011 Cropper et al.
20110172722 July 14, 2011 Verhulst et al.
20110208306 August 25, 2011 Farris
20110230965 September 22, 2011 Schell et al.
20110245926 October 6, 2011 Kitchen
20110307063 December 15, 2011 Schaller et al.
20120022651 January 26, 2012 Akyuz et al.
20120071977 March 22, 2012 Oglaza et al.
20120071980 March 22, 2012 Purcell et al.
20120089231 April 12, 2012 Prestigiacomo
20120123426 May 17, 2012 Quimo
20120136442 May 31, 2012 Kleiner
20120136448 May 31, 2012 Seifert et al.
20120150241 June 14, 2012 Ragab et al.
20120232552 September 13, 2012 Morgenstern Lopez et al.
20120232664 September 13, 2012 Ulrich, Jr. et al.
20120277861 November 1, 2012 Steele et al.
20120283748 November 8, 2012 Ortiz et al.
20120296171 November 22, 2012 Lovell et al.
20130053863 February 28, 2013 Juravic et al.
20130110239 May 2, 2013 Siegal et al.
20130116791 May 9, 2013 Theofilos
20130144391 June 6, 2013 Siegal et al.
20130158667 June 20, 2013 Tabor et al.
20130204374 August 8, 2013 Milella, Jr.
20130238098 September 12, 2013 Schaller et al.
20130282143 October 24, 2013 Perkins et al.
20130304070 November 14, 2013 Nelson et al.
20140058513 February 27, 2014 Gahman et al.
20140067073 March 6, 2014 Hauck
20140163326 June 12, 2014 Forsell
20140163560 June 12, 2014 Fenn et al.
20140235949 August 21, 2014 Smith
20140236296 August 21, 2014 Wagner et al.
20140249629 September 4, 2014 Moskowitz et al.
20140257297 September 11, 2014 Koogle, Jr. et al.
20140257484 September 11, 2014 Flower et al.
20140277481 September 18, 2014 Lee et al.
20140316427 October 23, 2014 Yoon et al.
20150012000 January 8, 2015 Siegal et al.
20150051701 February 19, 2015 Glerum et al.
20150100124 April 9, 2015 Whipple
20150112437 April 23, 2015 Davis et al.
20150112438 April 23, 2015 McLean
20150148908 May 28, 2015 Marino et al.
20150367487 December 24, 2015 Nino et al.
20160007979 January 14, 2016 Bhagat et al.
20160206442 July 21, 2016 Dvorak et al.
20160287409 October 6, 2016 Ziemek
20160367332 December 22, 2016 Shah et al.
20170007349 January 12, 2017 Solar et al.
20170135704 May 18, 2017 Abbasi
20170303938 October 26, 2017 Rindal et al.
20190167440 June 6, 2019 Lee et al.
20190216482 July 18, 2019 Huffmaster et al.
20190216612 July 18, 2019 Schaller et al.
20200345401 November 5, 2020 McHale et al.
20210113252 April 22, 2021 Ammerman et al.
20210154024 May 27, 2021 Lorang et al.
20210169459 June 10, 2021 Pacheco-Serrant et al.
20220031471 February 3, 2022 Hessler et al.
20220110650 April 14, 2022 Huffmaster et al.
20230051745 February 16, 2023 Pacheco-Serrant et al.
20230124332 April 20, 2023 Lorang et al.
Foreign Patent Documents
42 22 121 September 1993 DE
197 10 392 July 1999 DE
197 10 392 July 1999 DE
0 682 910 November 1995 EP
1 157 676 November 2001 EP
1 157 676 November 2001 EP
2900814 May 2006 FR
2 900 814 November 2007 FR
2002-28171 January 2002 JP
2002-028171 January 2002 JP
WO 95/025485 September 1995 WO
WO 98/017190 April 1998 WO
WO 98/034552 August 1998 WO
WO 98/34552 August 1998 WO
WO 99/021500 May 1999 WO
WO 99/21500 May 1999 WO
WO 99/047058 September 1999 WO
WO 00/074605 December 2000 WO
WO 00/74605 December 2000 WO
WO 01/001895 January 2001 WO
WO 03/024344 March 2003 WO
WO 2005/048856 June 2005 WO
WO 2006/042334 April 2006 WO
WO 2006/047587 May 2006 WO
WO 2006/047587 May 2006 WO
WO 2006/072941 July 2006 WO
WO 2006/072941 July 2006 WO
WO 2007/009107 January 2007 WO
WO 2007/079237 July 2007 WO
WO 2007/100914 September 2007 WO
WO 2008/021972 February 2008 WO
WO 2008/036505 March 2008 WO
WO 2008/036505 March 2008 WO
WO 2008/063435 May 2008 WO
WO 2008/084479 July 2008 WO
WO 2008/084479 July 2008 WO
WO 2008/103832 August 2008 WO
WO 2008/112308 September 2008 WO
WO 2010/008353 January 2010 WO
WO 2010/008353 January 2010 WO
WO 2011/150350 December 2011 WO
WO 2012/048187 April 2012 WO
WO 2012/178018 December 2012 WO
WO 2013/043850 March 2013 WO
WO 2014/158680 October 2014 WO
WO 2019/148083 August 2019 WO
WO 2019/178575 September 2019 WO
Other references
  • Official Communication in European Application No. 08730402.8, dated Feb. 18, 2013.
  • International Search Report and Written Opinion in International Application No. PCT/US2008/054590, dated Aug. 22, 2008.
  • International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2008/054590, dated Aug. 28, 2009.
  • International Search Report and Written Opinion in International Application No. PCT/US2019/015386, dated May 23, 2019.
  • International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2019/015386, dated Aug. 13, 2020.
  • International Search Report and Written Opinion in International Application No. PCT/US2019/022632, dated May 30, 2019.
  • International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2019/022632, dated Oct. 1, 2020.
  • International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2014/019246, dated Sep. 24, 2015.
  • Office Communication for U.S. Appl. No. 13/804,847, dated Jul. 13, 2015.
  • Office Communication for U.S. Appl. No. 13/804,847, dated Oct. 16, 2015.
  • Extended European Search Report for European Patent Application No. 11787510.4, dated Oct. 15, 2013.
  • International Search Report and Written Opinion for PCT Patent Application No. PCT/US2011/038377, dated Aug. 25, 2011.
  • International Search Report and Written Opinion for PCT Patent Application No. PCT/US2013/068906, dated Feb. 6, 2014.
  • International Search Report and Written Opinion in International Application No. PCT/US2014/019246, dated Aug. 19, 2014.
  • Office Action dated Jul. 2, 2015 for U.S. Appl. No. 13/803,322.
  • Office Action dated Apr. 4, 2016 for U.S. Appl. No. 13/803,322.
Patent History
Patent number: RE49994
Type: Grant
Filed: Mar 19, 2021
Date of Patent: Jun 4, 2024
Assignee: Spinal Elements, Inc. (Carlsbad, CA)
Inventors: James Lee (Los Gatos, CA), Jeffrey L. Emery (Emerald Hills, CA), Timothy McGrath (Fond du Lac, WI), Laurent Schaller (Genoa, NV), Andrew Huffmaster (Fremont, CA), Ebrahim Mohammad Quddus (Fremont, CA)
Primary Examiner: Matthew J Kasztejna
Application Number: 17/206,771
Classifications
Current U.S. Class: Joint Distractor (606/90)
International Classification: A61F 2/44 (20060101); A61B 17/88 (20060101); A61F 2/46 (20060101); A61F 2/30 (20060101);